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Adjuvant studies of Cytokines in DNA vaccine against viral haemorrhagic 
septicemia virus (VHSV) of Japanese flounder, Paralichthys olivaceus 
Emmadi Dhanwanthari 
Laboratory of Genetics and Biochemistry 
Tokyo University of Fisheries 
ABSTRACT 
Cytokines are low molecular weight soluble proteins secreted by the cells of the 
innate and adaptive immunity that mediate many of the functions of these cells. They are 
often pleotropic and redundant. Viral hemorrhagic septicemia is an infectious viral 
disease of fish, caused by viral hemorrhagic septicemia virus (VHSV) and is responsible 
for economic losses in aquaculture farms in Japan and around the world. DNA vaccine 
has been developed for VHSV, but to sustain the immune response of this DNA vaccine 
for a long time adjuvant studies are required. In the present study we described the 
adjuvant studies of IL-I~, IL-8 and JFCC I using VHSV as a model system. We also 
enumerated the gene expression profile of immune related genes of Japanese flounder 
kidney cells induced by IL-I~, IL-8 and JFCC I. 
The full length genes of IL-I~, IL-8 and JFCC I of Japanese flounder were cloned 
into the CMV driven DNA vaccine expression vector. VHS glycoprotein DNA was also 
cloned into expression vector. The plasmids were extracted in a large scale. The fish were 
co-administered by intra/muscular injection in 0.1 !!g of VHSV glycoprotein along with 
10 !!g each of IL-I~ , IL-8 and JFCC I respectively. After 8 days post-vaccination, the fish 
were challenged with I X I oj TClD 50 VHS virus intra/peritoneally. The cumulative 
mortalities and RPS values were recorded to study the adjuvant effects. For cDNA 
microarray analysis, I 0 ~g each of IL-I p, IL-8, JFCC I was injected into Japanese 
flounder fish and kidney was sampled at I day, 3 day and 7 day. cDN A was labeled with 
Cy3 and Cy5, hybridized to the microarray chip and the results were analyzed. 
Fourty eight percent mortality was observed in 0.1 glycoprotein vaccine group 
against 23-30 percent in cytokine adjuvant groups. The relative percentage survival was 
significantly high in 0.1 ~g VHS g along with I 0 ~g of adjuvants, compared with fish 
given the glycoprotein DNA vaccine alone. At least 18 % increase in the efficiency of the 
DNA vaccine was observed with adjuvants. 
Of 871 cDNAs on a microarray, 93 genes (10.7%) were up-regulated or down-
regulated by IL-I P at I, 3 and 7 days post injection. The induced up-regulated genes were 
highest on I day followed by 3 day and 7 day. Seven percent of known and 3.7% of 
unknown genes of the 871 tested genes were differentially expressed. Of the genes tested, 
7.4% were up-regulated and 3.3% were down regulated. Cytokine genes such as tumor 
necrosis factor, G-CSF and chemokine receptor A were induced in response to IL-I p. 
Cell surface antigens such as IgM, MHC class I and CD20 receptor were up-regulated. 
Signal transduction genes such as Toll-like receptor I and SH3P2 were also up-regulated. 
The glucocorticoid receptor and cAMP early repressor were down regulated in our 
microarray analysis. 
The induced genes were high on I day followed by 3 day and 7 day by IL-S 
injection. On the contrary, the induced gene expression was high on 3 day followed by I 
day and 7 day by JFCCI. Of the genes tested, 3.6% were up-regulated and 1.6% were 
down-regulated by IL-S. JFCC I up-regulated 6.1 % and down-regulated I % of the total 
tested genes. The important genes that up-regulated were Ig M, MHC class I , T cell 
receptor ~ , Ig D and heat shock factor binding protein by CXC chemokine. Whereas the 
JFCC I up-regulated CXC chemokine, CC chemokine receptor, Ig M, lysozyme and 
amyloid protein. 
In conclusion, IL-I~ , IL-S and JFCCI showed adjuvant effects in DNA vaccine 
against VHSV in our study. All these three genes are strong mediators of innate 
immunity, humoral immunity and inflammation processes. IL-I~, IL-S and JFCCI 
exhibited cellular immunity. IL-I ~ alone exhibited the signal transduction inducer 
property. Still further studies are needed especially in the quantification of dosage and 
duration of immunity to assess adjuvant properties of these cytokine genes. 
Chapter 1 
Introduction 
1.1. AQUACULTURE TREND IN 21" CENTURY: Fish provide a significant source 
of animal protein. Global production from capture fisheries and aquaculture is very 
significant for global food security, providing more than 15 percent of total animal 
protein supplies. In 200 I total fishery production excluding aquatic plants was reported to 
be 130.2 million tonnes, of which 37.9 million tonnes came from aquaculture practices. I 
Aquaculture production, excluding aquatic plants, reached 37.9 million tonnes by weight 
and 55.7 billion dollars by value in 2001. [n 2001 , more than 80% of the total world 
import value was concentrated in the developed countries. Japan was the major importer 
accounting for 23% of the total value. 1 According to FAO,2 the projections of world 
fishery production in 20 I 0 range between 107 and 144 million tonnes. Estimated 
quantities which will be available for human consumption range between 74 million 
tonnes and 114 million tonnes. Most of the increase in fi sh production is expected to 
corne from aquaculture which is growing rapidly. According to FAO statistics, 
aquaculture is growing more rapidly than all other animal food producing sectors. 
Worldwide, the sector has increased at an average compounded rate of 9.2 percent per 
year since 1970, compared with only 1.4 percent for capture fisheries and 2.8 percent for 
terrestrial farmed meat production systems. 
1.1.1. Japanese flounder culture: Japanese flounder, Paralichthys olivaceus is a 
temperate marine flat fish that belongs to the family Paraiichthyidae, Order 
Pleuronectijormes, and class Actinopterygii. Its common names are bastard halibut, olive 
flounder, Japanese flounder and hirame. Its habitat ranges from the western Pacific from 
Japan, Kurile Islands and the Korea peninsula to the South China Sea. Japanese flounder 
culture was initiated in Japan in the 1980s and widely introduced to Korea and China 
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during the latter half of 1980s. In 200 I, Japanese flounder production ranked fourth in 
overall marine fish culture in Japan. Its production was estimated at II billion yen, which 
corresponds to 4.8% of a total marine fish production of 230.5 billion yen (Gross 
Fisheries Output, 200 I, the ministry of agriculture, forestry and fisheries of Japan-
www.maff.gojp/esokuhoU/2002J2.pdf). Japanese flounder is a temperate marine species 
and grows fastest at 15 to 25 °C. It is usually cultured in land-based tanks in which the 
water temperature can be controlled. 
1.1.2. Viral diseases in Japanese flounder: Aquaculture production is mainly affected 
by the incidence of diseases originating from viral, bacterial and parasitic origin.34 It has 
been estimated that ten percent of the all cultured aquatic animals are lost because of 
infectious diseases alone. Japanese flounder is also susceptible to many viral and 
bacterial diseases. Some of the important viral diseases that have been identified in 
Japanese flounder are hirame rhabdovirus, viral hemorrhagic septicemia, viral nervous 
necrosis and viral ascites caused by bima virus. 
Viral hemorrhagic septicemia (VHS) is an infectious viral disease that causes 
serious economic problems in fish farms. This has been identified in Japanese flounder in 
Japan. The virus is placed within the family Rhabdoviridae and in the Novirhabdovirus 
genus. VHS generally occurs at a temperature range of 4-14 °C. The disease is 
characterized by high mortality, with the affected fish being dark, lethargic and showing 
haemorrhages at the base of fins and in the gills. Dead fish at this stage often have 
massive haemorrhages in the abdominal cavity. The second stage is one of chronic 
disease, where the predominant feature is a very black coloration, and anemia. The gills 
are very pale and exophthalmos is a common feature. The third clinical stage, from which 
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the virus is not usually isolated, is associated with the cessation of mortality, but affected 
fish show darkness and exophthalmos, but the main feature is swelling and discoloration 
of the kidney (www.fishpathogens.net). The viral genome is composed of an 
approximately ll-kb single-stranded RNA. It contains six genes in the order 3' -N-P-M-
G-NV-L-5' , which encode five structural proteins such as a nucleocapsid protein, 
polymerase associated protein, matrix protein, glycoprotein, non-structural protein and 
RNA dependent polymerase (www.fishpathogens.net) . 
Chemicals and antibiotics used for disease control have had undesirable side 
effects such as accumulation in the flesh of animals, development of drug resistance, and 
contamination of the aquatic environment.4 Researchers have shifted their focus to 
prevention of diseases, in particular vaccine development, to reduce the possihility of 
infections. The definite need to produce effective vaccines against a numher of viral and 
bacterial diseases has led to a better understanding of fish immunity and the factors that 
influence its function. 
1.2. IMMUNITY IN FISHES: In general, the immune response of animal species is of 
two types: innate immunity and adaptive immunity. Fish immunity exhibits similarities to 
the immunity other vertebrates and can be classified into these two general categories.s 
Innate immunity consists of mechanisms that exist before infection. It is capable of rapid 
responses to microbes, and reacts in essentially the same way to repeated infections6 The 
innate or non-specific immunity provides early lines of defense against inflammation, 
especially from microbial or pathogenic agents including ecological toxins and parasites 
breaching through the epithelial barrier7 .8 These barriers include skin, mucus, gill and a 
variety of cell types or substances. Invertebrates also possess an innate immune system.5 
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In contrast, adaptive or acquired immunity is more specific to the pathogens and responds 
to repeated exposures to the same microbe. The jawed fi shes from Chondrichthyes to 
Osteichthyes clearly show activities or pathways of adaptive immunity, including the 
complement pathway.s This immunity involves antigenic activation of specific reactive 
lymphocytes. Following antigen recognition, lymphocyte populations change, resulting 
in lymphocyte proliferation, antibody production and immunological memory induction.9 
Immune responses require the interaction of multiple cell types and mediators. Both 
innate and adaptive immunities require cytokines which regulate the communication 
between antigen-presenting cells (APCs), lymphocytes and other host cells in the course 
of an immune response. 10 
1.2.1. Cytokines as a link between innate and adaptive immunity: Cytokines are 
proteins secreted by the cells of innate and adaptive immunity that mediate many of the 
functions of these cells.6 Cytokines are produced in response to microbes and other 
antigens, and different cytokines stimulate diverse responses of cells involved in 
immunity and inflammation. In the activation phase of immune responses, cytokines 
stimulate the growth and differentiation of lymphocytes, and in the effector phases of 
innate and adaptive immunity, they activate different effector cells to eliminate microbes 
and other antigens. Cytokines also stimulate the development of hematopoietic cells.6 A 
generally accepted functional definition of cytokines distinguishes between type-I and 
type-2 cytokines. Type-I cytokines such as IL-2, LL-12, IL-IS, IFN-y, IFN-a and IFN-~ 
are involved in T helper I (Th-I) immune responses and induce cell mediated immunity. 
In contrast, type-2 cytokines such as IL-4, IL-5, IL-6, IL-IO and lL-13 are involved in 
5 
Th2 immune responses and promote humoral immunity and immune deviation to a non-
• 10 protective response. 
Different cytokines are involved in different functions . lL-2," lL_412 and TGFpll 
are involved in cell proliferation. [L_7'4 and lL_ISI S play important roles in cell survival. 
lL_I2'6 is important for cell differentiation. GM-CSF, lFNa and [L_101O are important in 
antigen presentation. Some cytokines are also involved in immune cell development, 
such as IL_7,17 SCF,18 SDFI9 and [L_IS2o or act on lymphoid organs, such as LT and 
TNF?I [n general, acute and chronic inflammations are induced and affected by 
cytokines such as [L-I , TNFa, [L-6, [L-12, GM-CSF, chemokines and [FNy. These 
cytokines are called pro inflammatory cytokines. Another cytokine group, which acts in 
part by reducing the production of proinflammatory cytokines, is termed anti-
inflammatory. Members of this group such as [L-IO lL-4, [L-13 and TGF-p, can reduce 
the production of IL-I , IL-12, [FNa and TNFa from macrophage. 
1.2.2. Cytokine genes in fish: Secombes et aln .n reviewed cytokine genes that have 
been identified in recent years. An inflammatory insult will result in a cytokine cascade 
where tumor necrosis factor is released, followed by interleukin-I p. Recently TNF-a 
sequences were published for Japanese flounder,24 rainbow trout25 and channel catfish?6 
lou et al.27 reported two isoforms of TNF in rainbow trout. TGF-p is a pleotropic 
cytokine involved in tissue remodeling, wound repair, development and haematopoiesis, 
and is expressed in wide range of cells and tissues. A full-length of cDNA has been 
sequenced in rainbow trout, and translates into a 382 amino acid precursor molecule22 
TGF-pi has been identified in Carp28 and sea bream29 lnterleukin-I P and other 
chemokines were also studied in fishes . 
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1.2.3.lnterleukin-Ip 
Evolution: Interleukin-l ~ (TL-l~) is a member of the IL-l cytokine family having a ~-
trefoil structure composed of l2-~ sheets.3o and plays a pivotal role in the inflammatory 
response as well as in the maturation and proliferation of many immune cell types. 31 Its 
recent discovery in teleost fish dates cytokine evolution at c.350 agon The intron-exon 
organization of the three lL-l genes (lL-l a, IL-l ~ and IL-l Ra) suggests duplication of a 
common gene some 350 million years ago. Before this common IL- l gene, there may 
have been an ancestral gene from which fibroblast growth factor (FGF) also evolved, 
since lL-l and FGF share significant amino acid homologies, lack a signal peptide and 
form an all ~-pleated sheet tertiary structure.31 IL-l~ is synthesized by activated 
monocytes and macrophages as a precursor with little activity. 
o Common ~-trefoil precursor 
dO lL.) family preclUS'" 
FOF P=IUS0tj 
IL-18 
o 1[..1 precursor 
,/ '\. 
O 0 IL-I ~ precursor 
/ '\. 
IL-la O 0 
IL-l ra IL-lP 
7 
Fig.1 lL-I Family (Secombes el al. , 1999i 2 
Structure: The genomic DNA and cDNA of many species have been cloned in mammals 
and fish. In fishes the cDNA has been cloned and sequenced in rainbow trout,33 carp,34 
seabass,35 and seabream]6 The translated open reading frames gave a predicted peptide 
with molecular weights ranging from 28-31 kD for different fish species. The precursor 
peptide doesn' t have a biological activity in manJIDals. The precursor is then processed 
by caspase-I, also called interleukin-I-converting enzyme (ICE), releasing a mature 
active peptide.37 The cleavage of prolL-1 ~ at the aspartic acid alanine positions (amino 
acids 116-117) is a property ofa specific intracellular cysteine protease known as ICE.38 
The aspartic acid at position 116 of the pro-IL-I ~ is the recognition amino acid for ICE 
cleavage. Prevention of the cleavage the ICE precursor may also account for apparent 
inhibition of IL-I ~ synthesis. ICEu cleaves the the ICE precursor and pro IL-I~ . It is 
presumed that ICE~ and y also process precursor ICE. ICE activity and [L-I ~ secretion 
also regulated by events associated with inflammation]9 Mammalian IL-I ~ precursor is 
cleaved by ICE at Asp-X bound (where X is normally a small hydrophobic residue) to 
yield a 17 kDa carboxyl terminus derived mature polypeptide which is then transported 
out of the cells, supporting the hypothesis that lL-I ~ post-translational processing 
involves a commitment to cell death.37 The gene ced-3 in the nematode, Caenorhabdilis 
elegans, codes for a protein homologous to human ICE.4o During embryonic 
development of the worm, this gene is expressed in specialized cells and is thought to be 
responsible for programmed cell death. 
Surprisingly, in teleosts the IL-\ ~ precursor sequenced to date lacked the 
interleukin-I-converting enzyme recognition site]5 Despite this difference from 
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mammalian IL-I p, the similarity in secondary structure is high.32 It is a common feature 
to have ATITA motifin the 3' UTR of all inflammatory molecules.41 Almost all teleosts 
IL-l ps cloned to date possess this A TIT A motifs in their 3' untranslating regions, 
suggesting that their mRNA expression is tightly regulated. The teleosts IL-l p show high 
homology among different fish species. Japanese flounder has highest homology with 
seabass IL-l p. The amino acid regions that form the secondary structure of 12 p-sheets 
were the areas showing the highest homology. The organization of the teleosts IL-l ps is 
different from that of mammals. Mammalian and carp IL-l p genes contain 7 exons42 
whereas the trout sequence consists of 6 exons.43 However the organization of the 
seabream IL-I p is different to those of mammals and fish and comprises only five 
exons
J 6 
Gene expression: In human monocytes, IL-I p mRNA levels ri se rapidly within 15 min 
but depending on the stimulant, start to fall after 4h. The decrease is due to the synthesis 
of a transcriptional repressor and a decrease in mRNA life.44 Using IL-I itself as a 
stimulant of its own gene expression, IL-I p mRNA levels are sustained for over 24 h.4s 
Raising cAMP levels in monocytes with histamine enhances IL-I p gene expression and 
protein synthesis46 Inhibition of translation by cyclohexamide results in enhanced 
splicing of exons, excision of introns and increased levels of mature mRNA. Thus 
synthesis of mature IL-I p mRNA requires an activation step to overcome an apparently 
intrinsic inhibition to process precursor mRNA.44 Dissociation between transcription and 
translation is the main characteristic feature of IL-I p47 and also of TNFa48 Even though 
there are vigorous signals for transcription by a variety of agents such as C5a, most of the 
IL-I p is degraded and no significant translation takes place and there is little significant 
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elongation of the peptide although the IL-l ~ mRNA assembles into large poly 
ribosomes.39 However, adding of bacterial endotoxin or IL-I itself to cells with high 
levels of steady state mRNA results in augmented translation.48 One possible explanation 
is that stabilization of the AU-rich 3' untranslated region takes place in cells stimulated 
with LPS. These AU-rich sequences are known to suppress normal hemoglobin synthesis. 
Another explanation is that IL-I stabilizes its own mRNA by preventing deadenylation, 
as it does for chemokine gro_aJ9 Removal of IL-I from cells after 2 h increases the 
shortening of poly (A) and IL-I apparently is an important regulator of gro synthesis 
because it prevents deadenylation. Of the several cytokines induced by IL-I , large 
amounts of the chemokine family are produced in response to low concentrations of IL-I. 
Following synthesis, pro IL-I ~ remains primarily cytosolic until it is cleaved and 
transported out of the cell. The IL-I ~ prop ieee (amino acids 1-116) is myristoylated on 
lysine residues4 9 Pro 1L-1 ~ has no known membrane form and proIL-I ~ is only 
marginally active.so Release of the mature IL-l~ appears to be linked to cleavage of the 
aspartic acid-alanine peptide cleavage by the ICE.39 
Usage of endotoxin or other microbial stimuli, and prostaglandins and 
prostacyclin had little effect on transcription but reduced translation of IL_l.s1 Blocking 
cyclooxigenase can increase production of IL-I , particularly when cells are stimulated by 
agents that stimulate large amounts of PGE. PGE-induced suppression of IL-I translation 
appears to be via the induction of cAMP. The addition of PGE or dibutyryl cAMP 
suppresses IL-I synthesis5l Histamine binding to the type-ll histamine receptor raises 
cAMP levels and histamine reduces LPS induced IL-I synthesis in human monocytes 
with little effect of IL-I gene expression 5 2 The effects of cAMP on IL-I synthesis and 
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gene expression are dependent on the type of stimulant and the conditions of cell culture. 
Histamine, which reduces LPS-induced IL-I synthesis via a cAMP pathway, enhances 
IL-I-induced [L-I synthesis and gene expression.51 Similarly, PGE2 enhances IL-I 
induced IL-I and IL-I-induced IL-I is reduced by cyclooxigenase inhibitorsS I Control of 
IL-I transcription and translation is affected by other cytokines. IL-I is a stimulus of its 
own gene expression and synthesis in blood mononuclear, fibroblasts , endothelial and 
smooth muscle cells.53 lNF,54 granulocyte-macrophage colony stimulating factor (GM-
CSF),51 and macrophage-CSF (M-CSF) also stimulate lL-1 production. IL-I transcription 
is suppressed by IL-4,55 IL_656 and transforming growth factor ~ (TGF-~)s l In general, 
corticosteroids inhibit the transcription ofiL-I, lNF and nearly all cytokines. In human 
volunteers injected with corticosteroids just before an intravenous injection of endotoxin, 
there are reduced levels of circulating IL-I~, lNF and IL_6.39 These reductions in IL-I~, 
lNF and IL-6 take place with out suppressing IL-I Ra productionJ9 Increased synthesis 
of hcB with decreased translocation of NFICB is thought to account for the suppressive 
effect of glucocorticoids on cytokine synthesis. 57 
Gene expression in Fish: In teleosts the expression ofIL-I~ was studied thoroughly. In 
rainbow trout there is no constitutive expression of IL-I ~ in lymphoid organs43 
However, challenge for 48 h with an attenuated Gram negative bacterial pathogen 
Aromonas salmonicida 58 can induce IL-I ~ transcription in a range of tissues, including 
blood, gill , kidney, liver and spleen, but not brain43 Similarly, stimulation of kidney 
leucocytes in vitro with LPS or PHA has been shown to induce IL-I ~ expressionn A 
number of factors have a pronounced effect on IL-I ~ rnRN A levels in rainbow trout head 
kidney leucocytes. LPS was used as an inducer of trout IL-I ~ mRNA, since it is the 
II 
classical stimulant of IL-I expression in many animal models.J1 Trout leucocytes can 
respond to levels of LPS as low as 0.1 ).lglml, although clearly this is a sub-optimal 
stimulation of IL-I ~ expression. Maximal stimulation was seen using doses of LPS> 1.5 
).lglml. This is much higher than the doses of LPS required for stimulation of IL-l P 
expression in mammalian monocytes, where concentrations as low as 10-20 pglml are 
sufficient. 5 I The expression occurs quickly following stimulation with LPS, with 
transcripts being detectable by I h post-stimulation. Peak transcript levels appeared to 
occur between 2.5 and 4 h post-stimulation. Transcript levels were still high at 8 h post-
stimulation but then declined markedly by 24 h and were not detectable by 72 h. The 
rapid decline in IL-l P transcript following stimulation with LPS has been attributed to the 
synthesis of a transcriptional repressor and unstable mRNA due to the presence of 
AUUUA motifs in the 3' UTRJ1 which are also present in the trout transcript. IL-IP 
expression in cultured trout head kidney leucocytes was demonstrated with respect to 
temperature. 59 They reported that the temperature appears to be a relatively quick event, 
in that cells cultured at 14 °C and then transferred to 4 °c or 22 °C at the time of 
stimulation with LPS show an impact of changing temperature relative to cells kept at 14 
°c . However, transfer to 22 °C at the time of stimulation did not result in as large an 
effect on IL-I P expression as seen in cells cultured for 5 days at 22 °C prior to 
stimulation. In contrast, when cells cultured at 14 °c were transferred to 4 °c at the time 
of LPS stimulation there was a more marked inhibition of 1L-1 P expression relative to 
cells cultured at 4 °c for 5 days prior to stimulation. It is clear from the above observation 
that low temperatures markedly inhibit the transcription of the IL-l P gene in trout 
leucocytes and this is likely to lead to poor IL-I P protein production. Cortisol was also 
12 
shown to inhibit [L-I ~ transcription by trout head kidney leucocytes.s9 Engelsma el al.42 
studied the in vivo expression of carp IL-I ~ mRNA in mUltiple organs. They found a 
predominant expression in the immune organs head kidney and spleen. In carp, addition 
of PMA or LPS in vitro resulted in expression of both intron-containing and fully spliced 
IL-I ~ RNA products within I h. Expression of intron-containing products was seen until 
3 h after LPS stimulation and fully spliced products exceeded 8 h after stimulation with a 
, 
peak at 2-3 h. The NF-lCB inhibitor, POTC, was shown to completely suppress the LPS-
induced expression, clearly indicating that the NF-lCB transcription factor is involved in 
the LPS-induced expression of carp IL_I ~.42 Jarrous and Kaempfer44 have described the 
retinoic acid (RA)-induced lL-I ~ expression in human peripheral blood mononuclear 
cells. RA induces the accumulation of precursor transcripts but fails to yield mature 
RNA. In carp similar expression pattern was observed42 Tucker el al60 reported 
detection of bombarded CAT (reporter gene) expression in fish of the CMV promoter 
group and fish of the SV -40 promoter group after plasmid 0 A injection. The CAT 
expression in the fish group injected with CMV promoter was higher than that in the fish 
group injected with SV-40 promoter. Kono el al.6J studied the IL-I~ protein expression in 
serum on I, 3 and 5 days after pCMV -lL-I ~ plasmid injection. 
1.2.4. Cbemokines 
Chemokines (chemoattractant cytokines) are a complex super family of small (6-14 kOa) 
secreted proteins that were initially characterized through their chemotactic effects on a 
variety of leucocytes.62 To date, at least 40 distinct chemokines have been well 
characterized. Chemokines have a plethora of overlapping functions and are produced by 
a variety of cell types during an inflammatory response. Generally, chemokines act on 
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more than one type of leucocyte, and in vitro responses include chemotaxis, enzyme 
release from intracellular stores, oxygen radical formation , and shape change through 
cytoskeletal rearrangement, generation of lipid mediators and induction of adhesion to 
endothelium or extracellular-matrix proteins.62 Lymphocyte traffic is important in 
regulation of the immune system. Apart from lymphocyte migration, chemokines also 
act on angiogenesislangiostasis, lymphoid organ development, cell recruitment, Thlrrh2 
development and metastasis.6l Chemokines within a particular group show closely 
similar structures, with sequence homologies ranging from 20% to 90%. Chemokine 
domains are defined by the presence of four cysteines in highly conserved positions. One 
major chemokine subfamily is called 'CXC' because the two amino acids nearest the N-
termini of these proteins are separated by a single amino acid. This is in contrast to 
another subfamily which is called 'CC' because these cysteines are adjacent.64 CXlC or 15 
chemokines form a unique chemokine group, exhibiting structural distinctions not found 
in other chemokines. Three amino acids interrupt the first and second cysteines forming a 
mucin-like stalk and both transmembrane and cytoplasmic domains.6s C (y) chemokines, 
the remaining subfamily of chemokines, lack the second cysteine, yet are functional. 66 
Evolution: Amino acid sequence analysis of CXC and CC chemokines indicate that the 
mammalian and primitive vertebrate chemokines diverged from the ancestral gene before 
the appearance of mammals6 7 CXC and CC chemokine receptors branched early from an 
ancestral gene before the divergence of the mammalian order and it has been suggested 
that they have co-evolved with chemokine ligands.68 However, the evolutionary track of 
the receptor gene was possibly different from that of the chemokines.67 Almost all CC 
cbemokine genes and CXC chemokine genes are grouped at 17q 11.2-12 and at 4q 13 
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respectively, suggesting that chemokines arose by duplication and divergence from a 
primordial chemokine gene, with an early split into the two loci . Similar clustering has 
been observed among genes encoding chemokine receptors. Mice appear to have fewer 
chemokines than humans and some of these chemokines may have occurred recently in 
evolutionary terms.64 Chemokines have been found in non-mammalian vertebrates such 
as birds and frogs. Sick et al.69 reported two novel CC and CXC chemokines from a 
chicken macrophage cell line upon stimulation with LPS. This CC chemokine is a 
mammalian MIP-l P homologue and the CXC chemokine is an ortholog of mammalian 
human IL-S. Hughes et al70 identified three other types of CC chemokines from chicken. 
Their DNA sequences share identity with MIP-3a, RANTES and several CC chemokines. 
Phylogenetic tree analysis suggests that individual chicken and human chemokines were 
derived from common ancestral genes, thus reflecting their genomic positions. Lam 71 
also reported a MIP-I P like compound in the supernatants of chicken leukocytes after 
infection with Mycoplasma gallisepticum. The supernatants showed chemotactic activity 
similar to human MIP-I P but could not be neutralized by antibody to MIP-I p, indicating 
more than one chemoattractant was released from chicken leukocytes. CXC chemokine in 
frog (Xenopus laevis), xSDF-I , has been reportedn It differs considerably in primary 
structure from its mammalian counterpart but, it is indistinguishable from human SDF-I 
in its ability to activate both X laevis CXC chemokine receptor (xCXCR4) and human 
CXC chemokine receptor (hCXCR4). Braun et a/.72 suggested the possibility that these 
receptors have maintained evolutionary distance between Xenopus and living mammals. 
Structure: The primary sequence of chemokines is defined by their four invariant 
cysteine residues that form disulfide bonds. The amino acid sequence identities among 
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chemokines vary from less than 20% to over 90%. The presence of a putative signal 
peptide gives rise to a secreted sequence for each chemokine. A prominent secondary 
structural feature of chemokines is the triple-stranded antiparallel sheet that forms a sheet 
floor across which lies hydrophobic C-terminal helix. Proudfoot el alB summarized that 
the amino acid sequences at the N-terminus preceding the first cysteine are flexible , with 
no specified structure. It is believed that this plays a role in activation during the process 
of chemokine receptor binding. The special relationship of the N-terminus, sheet and 
helix is maintained by two disulfide bonds. The three structural domains have distinct 
functions. The N-terminus is essential for the activation of G protein-coupled receptors74 
The N-terminus and the sheet provide a scaffold for quaternary interactions resulting in 
high-affinity ligand binding to G protein-coupled receptors and the formation of 
chemokine dimers. Following the first two cysteines is a region of the structure 
approximately 10 amino acid residues long called the N-Ioop. This N-Ioop plays an 
important role in receptor binding. One strand of a 310 helix follows the N-Ioop and is 
preceded by lhree p-strands and a C-terminal helix. The p-strands at the 30s, 40s and 50s 
loops, for which the numbers represent the residues of the mature protein. The secondary 
structure of a chemokine is formed by two disulfide bridges. The first disulfide bridge is 
formed by the first and third cysteines whi Ie the second bridge is arranged by the pair of 
second and fourth cysteines.75 The C-terminal helix of some chemokines has been shown 
to interact with low-affinity glycosaminoglycan (GAGs) that are found on cell surfaces 
and matrix proteins.76 The basic charge of these ligands accounts for their heparin-
binding properties. The GAG-binding capabilities of the chemokines are reported to 
facilitate receptor interactions and the haptotactic migration of receptor-bearing cells over 
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matrix proteins and cellular faces. Some chemokines contain consensus sites for N-linked 
and/or O-linked glycosylation. The glycosylation may play a role in prolonging the 
chemokine half-life, and may improve GAG binding. 
CXC chemokines: IL-8, NAP-2, ENA-78, GROn, GRO~, GROy, and GCP-2 are 
members of the CXC subfamily. The CXC subfamily is subdivided into ELR+ and non-
ELR CXC chemokines based on the presence or absence of a Glu-Leu-Arg tripeptide 
sequence adjacent to the CXC motif. ELR-containing CXC chemokines include lL-8, 
ENA-78, and GRO n, ~,and y. The non-ELR CXC chemokines include IP-IO and SDF-
\.77 lL-8 is the prototype molecule. IL-8 was originally purified as a monocyte-derived 
factor that attracts neutrophils, but not monocytes. lL-8 is produced by a variety of cell 
types including monocytes, T lymphocytes, neutrophils, fibroblasts and endothelium. lL-
8 induces T lymphocyte chemotaxis and angiogenesis.64 The IL-8 amino acid sequences 
have variable lengths due to extensions at the N-terminus. IL-8 is a potent neutrophil 
chemoattractant, which is mainly due to the presence of an ELR motif between the N-
terminus and the first cysteine residue, at positions 4, 5, and 6J8 This ELR motif is 
essential for high-affinity binding to CXCR2.79 The ELR+ CXC chemokines promote the 
adherence of neutrophils to endothelial cells. A gradient of chemokines promotes 
diapedesis and migration toward inflammatory sites, with the neutrophils associating with 
matrix proteins and cell surfacesM Jones e l al. 80 reported that neutrophil degranulation 
may be achieved more readily by IL-8-induced activation of CXCRI than CXCR2. The 
ELR+ CXC chemokines elicit chemotactic activity in endothelial cells.8! The ELK CXC 
chemokines such as lP-l 0, MIG, and 1-T AC, which all use CXCR3, are chemotactic for 
activated T cells and monocytes. Both lP-1O and MIG have potent angiostatic effects.77 
17 
The CXC chemokines are also reported to play roles in homeostatic development. 
One of the CXC chemokines, SDF-I, was identified as a pre-B cell growth-stimulating 
factor (PBSF). SDF-I acts as a homeostatic hematopoietic hormone that is critical for 
homing and angiogenesis more so than as a proinilammatory chemokine.82 SDF-I is 
considered as a primitive chemokine due to its location on chromosome 10, whereas the 
other CXC chemokines are located on chromosome 4. This suggests SDF-I probably did 
not arise by gene duplication with other chemokines. Furthermore, SDF-I exhibits 
equidistant sequence homology to CXC and CC chemokines. Unlike other chemokines, 
which are highly divergent, SDF-I is highly conserved, showing only one amino acid 
difference between humans and mouse.82 SDF-I is expressed by a wide variety of cells 
and tissues. It can attract a broad spectrum of target cells because its receptor (CXCR4) is 
widely distributed on neutrophils, monocytes, T and B cells, CD34+ hematopoietic 
progenitor cells, bone marrow-derived dendritic cells, megakaryocytes, endothelial cells, 
neurons, astroglial cells, and gastrointestinal epithelial lining cells.82 
CC chemokines: The CC chemokines generally target mononuclear cells rather than 
neutrophils and are either pro-inflammatory or homeostatic mediators. Based on their 
similarities of amino acid sequences and chromosomal location. CC chemokines are 
subdivided into 3 subgroups, the MCP/eotaxin subgroup, the MlP-\ aI~ subgroup, and the 
1-309 subgroup. Members of the MCP/eotaxin subgroup of CC chemokines are closely 
related in chromosome location, gene and protein structure and receptor utilization.83 
They attract basophils and mast cells and can induce basophil de-granulation with 
histamine release.84 
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A second subgroup of CC chemokines includes macrophage inflammatory 
protein-I (MIP-Ia), MIP-IP, RANTES and PARe. The CC chemokine subgroup ofMIP-
la, MIP-IP and RANTES shows close relationships in human and mouse.8l MIP-Ia and 
MIP-I P share high percentage similarity in terms of amino acid and nucleotide sequences 
at 68% and 69%, respectively. Their high similarity is due to their co-evolution from the 
same primordial ancestral gene and duplication.86 Peptidoglycans consist of heparin, 
heparan sulfate and chondroitin sulfate. These are located at the surface of endothelial 
cells or in the extracellular matrix. It is believed that the binding of chemokines to 
peptidoglycans establishes an immobilized gradient, which facilitates their function. Ali 
e/ a/.87 reported that the binding of chemokines to peptidoglycans is not a prerequisite for 
their function, but might enhance their bioactivity. MlP-I a and MIP-I P elicit local 
inflammatory response in vitro. MIP-l a and MIP-I P show chemotactic activities on 
lymphocytes using a microchemotaxis system.88 In the central nervous system, where 
leukocytes exhibit chemokine receptors, MIP-l a and MCP-I show high affinity to 
astrocytes after stimulation with IL-IP and TNF-a.89 This suggests a role of these 
chemokines in central nervous system inflammation. To investigate in vivo activities of 
human MlP-Ia, Lee el a/.9O studied cell activation after intradermal injection of human 
subjects. Although no acute cutaneous or systemic reactions were observed, the 
activation of endothelial cells was suggested by the expression of E-selectin. During the 
tissue repair process, murine MIP-I a shows effective chemotactic activity on 
macrophages. So far, two chemokine receptors (CCR I and CCRS) have been identified 
for one type of MIP-I a (LD78a), whereas three receptors were reported for another type 
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of MIP-Ia (LD78~) . 64 CCRS is the only chemokine receptor that binds with MIP-l ~ ;64 
thus, MIP-I a is a more potent attractant of mononuclear cells than MIP-I~ . 
The 1-309 subgroup of the CC chemokines consisting of 1-309, HCC-2, CK~8 , 
and SLC each contain at least six cysteines9 1.94 In 1-309, HCC-2, and MPIFI , an 
additional cysteine is located within the sheet domain and a second one is located at the 
C-terminal helix. These cysteines may form a third disulfide bond anchoring the C-
terminal helix to the sheet. SLC has two cysteines on the C-terminal domain. Eotaxin 2 
has an unpaired fifth cysteine at the C-terminus.92 
Chemokines in Fish: Fish chemokines can be grouped into three subfamilies; CC, CXC 
and C chemokines. The CX3C chemokine subfamily has not been reported until now. 
The flfSt fish chemokine, CK - I, was reported by Dixon el 0/95 from trout. CK -I has four 
highly conserved cysteines of CC chemokine structure, with a gene structure consisting 
of 4 exons and 3 introns, which is more similar to CXC chemokines than to the CC 
chemokines. The Japanese flounder CC chemokine gene, in contrast, consists of 3 exons 
and 2 introns.96 Kattiya el 01.97 identified a novel CC chemokine gene designated as Paol-
SCYAlO4 in Japanese flounder and analysed its function. Also, trout CK- I has two 
additional cysteines which are found in the C6-~ chemokine subfamily.75 Other fish CC 
chemokines have also been described based on their cDNA sequences. Fujiki el 01. 98 
reported one cDNA nucleotide sequence from carp leukocytes using suppression 
subtractive hybridization (SSH). This cDNA showed more similarity to the mammalian 
monocyte chemotactic protein (MCP) than to the trout CK-l , including the tyrosine and 
aspartate residues which are conserved in human MCP-I. Suppression subtractive 
hybridization was also performed by Liu el 01.99 for cloning a novel CC chemokine gene 
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in rainbow trout (trout CK-2). Trout CK-2 showed four conserved cysteines resembling 
that of mammalian CC chemokines with 20% identity at the amino acid level. The amino 
acid sequence of trout CK-2 is 44% identical to carp CC chemokine,lOo which is higher 
than trout CK-I identity (20%). In a recent report, Kuroda el a/. lo l described several CC 
chemokines: seven types from cichIid fish and one type from cat shark. The detection of 
a cat shark CC chemokine implied the emergence of a CC chemokine even in 
cartilaginous fishes. Phylogenetic analysis of currently available chemokine sequences, 
however, does not reveal any clear evidence on the orthology of fish and human 
chemokines. Alignment of fish and human CC chemokines showed that only four 
cysteine residues are shared by all of its members. However, several residues are 
partially conserved among the majority of those CC chemokines, including a tyrosine, 
which plays a role in receptor binding in human MCP_I. lo2 It should be noted that within 
human CC chemokines, human MCP-l is the closest CC chemokine to fish CC 
chemokines, including Japanese flounder CC chemokine,96 carp CC chemokine99 and 
cichlid CC chemokines. lol 
CXC chemokines in fish were also described in terms of their sequences. The 
first CXC chemokine in fish, an IL-S homolog in lamprey, was reported by Najakshin et 
al. 103 This CXC chemokine was screened using subtractive hybridization similar to carp 
CC chemokine and trout CK-2. Its amino acid sequence shares 32% similarity with 
human IL-S. This finding indicates that the CXC chemokine gene arose at the time of the 
appearance of jawless fish. Other fish CXC chemokines have also reported similarity 
with IL-S; e.g. Japanese flounder,90 rainbow trout,98.104-IOS banded dogfish,I06 silver 
chimaera,107 and carp.108-109 In mammalian and chicken IL-S, there is the ELR motif 
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(Glu-Leu-Arg) immediately before the CXC sequence. The presence of an ELR motif is 
important for neutrophil attraction, as this affects its binding to specific receptors.78 All 
fish CXC chemokines lack the ELR moti f immediately upstream of the CXC sequence, 
this being replaced with other moti fs, e.g. the DLR motif in trout lL_8. IOS The only 
reported C chemokine in fish was found in the pufferfish.ll o This C chemokine, 
designated jCLI , possesses both the third and fourth conserved cysteines similar to other 
chemokines, but has only one N-terminal cysteine. It is functional and is expressed in 
the eye, gill , heart, muscle, skin and stomach. It shows 28% identity to both the human 
chemokine CCL28 and the zebrafish chemokine CCLl , but does not show a human 
ortholog by the BLAST program. The authors suggested the possibility that the BLAST 
parameters may not be optimal for detecting the human ortholog, since it has a short 
encoded protein and there is divergence in distinct species of cytokine genes. 
Fujiki el al.98 reported several copies (at least four) of rainbow trout IL-8. In 
contrast, trout CK_1 9s and CK-2 99 showed only one or two partial copies. Functional 
aspects of CXC chemokine action in fish have been demonstrated using human 
recombinant IL-8 in carp neutrophilic granulocyte-enriched leukocytes displaying 
chemotactic activity. 109 
1.3. CYTOKINES AND CHEMOKINES AS ADJUVANTS IN DNA 
IMMUNIZATIONS: Genetic immunization involves the direct in vivo transfection of 
antigen-encoding plasmid DNA into mammalian cells. The expression vector causes de 
novo production of antigens in transfected cells which, in tum, initiate an immune 
response. The use of plasmid DNA as vaccines or imrnunotherapeutics has been 
investigated in a number of species using a variety of infectious agents. I I I Plasmid DNA 
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vaccines were capable of eliciting humoral and cellular immune responses against the 
vaccine encoded antigen.112 Plasmid DNA vaccines provide several advantages over 
other types of vaccine technologies currently in use: a) DNA vaccines, in contrast to 
conventional subunit vaccines, allow for the encoded antigen to be efficiently processed 
and presented by the major histocompatibility complex (MHC) class I antigen processing 
pathway, which is critical for the induction of CDS+ T-cell mediated responses. In this 
way, plasmid DNA vaccines perform similarly to live viral vaccine vectors but without 
the associated safety concerns; b) Plasmid DNA vaccines are easily manipulated using 
standard molecular biology techniques and scalable manufacturing methods are readily 
available; c) Due to the relative simplicity and inherent stability of DNA vaccines it is 
likely that vaccine distribution and administration will prove to be cost effective and 
relatively easy; and d) DNA vaccines are inherently safe since most DNA vaccine 
plasmids exist in a circular form, they do not integrate into the host genome and fail to 
I· 11 2 rep Icate. 
DNA vaccines can be delivered by a number of routes (i.e., intradermal, mucosal and 
intramuscular) and by variety of techniques, (i.e., via needle and syringe, gene gun). To 
date, the most commonly used delivery route has been via intramuscular inoculation. 
Following delivery of plasmid DNA into the muscle, the vaccine DNA is taken up 
primarily by monocytes and to some extent by bone marrow derived antigen presenting 
cells (APCs). Once taken up by APCs, the DNA encoded vaccine antigen is expressed 
and subsequently processed and presented to the immune system in association with 
MHC class I molecules. Foreign antigen expression and presentation by MHC class I 
molecules is necessary to prime naIve CDS+ T -cells to become effector cells. In addition, 
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monocytes can secrete a foreign antigen for phagocytosis by professional APCs for 
presentation to the immune system in association with MHC class II molecules. 
Exogenous vaccine antigen expression thus results in the induction of antibody and CD4+ 
T-helper cell immune responses 112 A variety of approaches have been taken to augment 
and modulate immunogenicity and efficacy of plasmid DNA vaccines. These approaches 
have included targeting DNA vaccine plasmids to APCs, enhancing foreign antigen 
transcription and translation, targeting the expressed foreign antigen to APCs, enhancing 
foreign antigen processing and MHC-restricted presentation through ubiquitination. 
However the approach that seems to offer the most promise is the co-delivery of plasmid 
based genetic adjuvants, including cytokines, chemokines and co-stimulatory molecules. 
In 1993 it was demonstrated that the direct intramuscular injection of a cytokine 
expressing plasmid DNA resulted in the in vivo production of biologically active 
cytokine. 113 
Effect of cytokines targeting APCs; Vector-encoded antigens are most likely presented 
by professional APCs, such as dendritic cells, that are present throughout most 
mammalian tissues. Muscle cells express low levels of MHC class I detenninants, but 
lack MHC class II molecules, such as B7.1 or B7.2, that are crucial for receptor binding 
to CD4+ T cells and are required as second signals for T cell activation. 114 APCs, in 
contrast, express both MHC class I and class II detenninants, as well as co-stimulatory 
molecules. Furthennore, APCs participate in inflammatory reactions by expressing 
cytokine receptors and secreting cytokines. These characteristics allow APC to become 
activated upon a number of signals that contribute to the initiation of an innate host 
response. Upon activation, APC up-regulate expression of both MHC class [ and classII 
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determinants and co-stimulatory molecules, which facilitates the display of antigenic 
peptide-MHC complexes in a form recognizable by T cells. Upon activation, APCs also 
become mobile and migrate to draining lymphatic tissues, where they initiate T cell 
activation and production of cytokines including, IL-12 and IFNy. The result is an 
activation of inflammatory cells, including macrophages, stimulation of specific 
lymphocytes such as B-cells and production of other cytokines, such as [FNa, IL-I , IL-6, 
TNF a and GM-CSF.III Granulocyte/macrophage-CSF, a cytokine secreted by multiple 
cells is able to stimulate and recruit professional APCs, which makes it exceedingly 
useful as an adjuvant to vaccines. I I S 
Effect of cytokines on Tb cells: Th cell response to genetic immunization by using 
cytokines that directly affect T cell activation was well studied in mammalian models. 
Specifically, coinjection of 11-2, IL-12, IL-4 and IL-IO , and GM-CSF along with a 
DNA vaccine construct encoding for simian immunodeficiency virus (SIV) gag/pol 
proteins resulted in increased levels of antigen specific-antibodies. I 16 
Pro-inflammatory cytokines sucb as IL-lp, IL-S and MIP-la as adjuvants: IL-I is a 
cytokine with very potent inflammatory and pyrogenic activity and as a result the clinical 
development of IL-1 as a safe and efficacious vaccine adjuvant may be difficult. Despite 
these concerns, the use of IL-I as a DNA vaccine adjuvant has met with some success. I 12 
The ability of IL-I ~ to augment the immune response to a DNA vaccine expressed 
antigen was first explored by Hakim el al.1I7 The plasmid expressed TSA/IL-I ~ fusion 
protein was shown to elicit an increased antigen-specific IgG response and increased 
survival after lethal tumor challege. 1I7 In contrast, the co-administration of a plasmid 
expressing the full length [L-I ~ protein with a DNA vaccine expressing a soluble form of 
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the bovine herpes virus-I gO protein failed to augment gO-specific serum [gG titres. 1I2 
The ability of [L-8 to modulate the immune response elicited by DNA vaccination was 
first demonstrated in the mouse model of HSV infection. I IS [n this study 1L-8 co-
administration with a DNA vaccine expressing the HSV gO protein resulted in a more 
Th-I like immune response characterized by a slight increase in gO-specific [gG antibody 
titres and increased survival after intravaginal HSV challenge. M[P-I a has been shown to 
up-regulate IFN-y production by CD4+ T-cells"9 suggesting that MIP-Ia may be useful 
as genetic adjuvant by enhancing Th-I like cell-mediated immune responses. The first 
study to evaluate M[P-I a as a genetic adjuvant was done in mice. The intranasal or 
intramuscular inoculation of a DNA encoding M[P-Ia with a plasmid DNA expressing 
HN -I env resulted in increased serum [gG and increased mucosal [gG and [gA antibody 
responses. I2O [n addition MIP-I a co-administration resulted in an increased [gG2a and 
decreased IgG I antibody isotype response, as well as an increased DTH and CTL 
response characteristic of a Thl-like immune response. 120 Sin el al. ll s showed that the 
intramuscular co-administration of M[P-Ia with a DNA vaccine expressing HSV-2 gO 
resulted in only a slight increase in the gO-specific serum IgG antibody response. In 
contrast, the intramuscular injection of MlP-Ia with HSV-2 gO resulted in a more Th2-
like immune response with increased IgG I, decreased IgG2a and increased mortality 
after intravaginal challenge with HSV -2. Eo el al. 12I working in the mouse model also 
showed that the intramuscular administration of M1P-Ia with a DNA vaccine encoding 
HSV gB resulted in a more Th-I like immune response and increased protection after 
intravaginal challenge with HSV -I and also the route of cytokine administration may 
impact on the overall immunomodulatory effect of MLP-I a . 
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1.3.1. DNA vaccine and adjuvants technology in Aquaculture: Infectious diseases 
have been a major impediment to the development and profitability of fish farms. 
Vaccines offer the most efficient way to control infectious pathogens, but in the 
aquaculture industry they are in a relatively early phase of development. Some DNA 
vaccines have been developed for viral di seases such as Viral haemorrhagic septicaemia 
virus (VHSV) in Japanese flounderl22, Hirame rhabdovirus (HRV) in Japanese 
flounder,m Noda virus in turobot l24 and infectious haematopoietic necrosis virus (IHNV) 
in rainbow trout. 125 Adjuvants in DNA vaccinations in aquaculture have not been tried so 
far except for lL-1 p.1 26 Byon e l a/.122 used the VHS glycoprotein gene (G) and showed 
that it was able to induce protective immunity against VHS that lasted for 21 days. The 
microarray analysis showed that the G gene induced non-specific immune response genes 
such as NK, Kupffer cell receptor, MIP-l a and MX I protein gene and specific immune-
related gene such as CD 20 receptor, CDS alpha chain, CD40 and B lymphocyte cell 
adhesion molecule. Takano el a/. m developed a DNA vaccine using HRV glycoprotein 
gene (HRV g) which provided strong protection against hirame rhabdovirus in Japanese 
flounder. They also conducted a real- time PCR analysis to quantity immune related 
genes such as MHC class la, Ua, Up, TCR-a, PI , P2 and y to characterize the immune 
response at I and 7 days after DNA vaccination and found that the copy numbers were at 
least 2-fold higher than those of non-vaccinated fish. Sommerset e l a/. 124 developed a 
DNA vaccine for viral nervous necrosis in turbot using VHSV glycoprotein gene. They 
demonstrated the cross protection ability of the rhabdoviral glycoprotein genes against 
noda virus challenge in turbot. Rainbow trout vaccinated with DNA expressing the G 
protein of infectious haematopoietic necrosis virus had a relative percentage survival 
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(RPS) of 75% with live virus challenge. 125 Yin and Kwang126 demonstrated the immuno 
adjuvant properties of IL-\ ~ in carp against Aeromonas hydrophila and found that the 
mean agglutinating antibody titre at 3 weeks post-vaccination showed that that the titre of 
the titre of the immune group injected with killed A.hydrophila cells plus recombinant IL-
I ~ peptide was significantly higher than that of the group injected with killed bacterial 
cells alone. 
1.4. OBJECTIVES OF THE PRESENT STUDY 
The direct injection of a naked plasmid DNA vaccine encoding a foreign antigen results 
in plasmid uptake and protein expression leading to the induction of antigen-specific 
cellular and humoral immune responses. One approach to improve the immunogenicity of 
DNA vaccines is through the co-delivery of cytokine expression plasmids as adjuvants. 
Plasmid DNA-encoded immunomodulatory cytokines not only alter the magnitude and 
direction of the DNA vaccine-elicited immune response, but can also improve vaccine 
efficacy. In the present study, we used IL-l~, IL-8 and JFCCI as genetic adjuvants in 
viral haemorrahagic septicemia virus glycoprotein (VHSg) DNA vaccine to enhance the 
efficiency of glycoprotein gene. The second part of the strategy was to estimate the 
immunomodulatory properties and the expression pattern of various immune-related 
genes induced in response to these three cytokines by using cDNA microarrays. 
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Chapter 2 
Transcriptional profile of IL-tp induced kidney cells of 
Japanese flounder, Paralichthys olivaceus 
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ABSTRACT: IL-I P cDNA of Japanese flounder was found to consist of 1,329 bp, 
encoded 247 amino acid residues. Among the fish lL-I ps in the databases, the one with 
the highest identity of Japanese flounder [L-I p was that of seabass (62% identity). The 
expression of [L-I p was induced by treattnent with ConA/PMA and LPS. The copy 
number of lL-I p mRNA was increased 30 fold after stimulation with ConA/PMA. Of 
871 cDNAs on a microarray, 93 genes (10.7%) were up-regulated or down-regulated by 
[L-I P at I, 3 and 7 days post injection. The induced gene expression was highest on I 
day followed by 3 day and 7 day. Seven percent of known and 3.7% of unknown genes of 
the 871 tested genes were differentially expressed. Of the genes tested, 7.4% were up-
regulated and 3.3% were down regulated. Cytokine genes such as tumor necrosis factor, 
G-CSF and chemokine receptor A were induced in response to IL-I p. Cell surface 
antigens such as [gM, MHC class [ and CD20 receptor were up-regulated. Signal 
transduction genes such as Toll-like receptor I and SH3P2 were also up-regulated. The 
glucocorticoid receptor and cAMP early repressor were down regulated in our microarray 
analysis. 




Interleukin-I~ is an IL-I cytokine with a beta trefoi l structure that is composed of 
12 beta sheets, I and plays a pivotal role in the inflammatory response as well as in the 
maturation and proliferation of many immune cell typeS2 Recently, IL-I~ cDNAs and 
genes have been cloned from different fish species.) Expression of several humoral and 
cellular factors, production of reactive metabolites and secretion of hostile molecules 
have been suggested to depend on the expression of 1L-1 ~ in mammals.4 
DNA microarray technology is a latest technology to determine the expression 
profile of many immune related genes of Japanese flounder in a short period of time. The 
most important application of microarrays is in the study of differential gene expression 
in disease and health, and in normal and abnormal physiological and immunological 
responses.s Microarrays thus identifying all the genes that are turned on at the site of 
infection in vivo. They can also be used to study the response of a host to challenge with 
the pathogen such as a cytokine or gene pathways, signaling pathways and identification 
of immune gene responses.s The microarray analysis would identify cytokine-responsive 
genes and help develop models for disease investigation.6 A microarray analysis of IL-l ~ 
identified alterations in the expression of multiple transcription factors, cytokines, growth 
factors and their receptors, adhesion molecules, proteases and signaling intermediates that 
may contribute to inflammation in arthritis.' 
In this study, we determined a full length cDNA of Japanese flounder 1L-1~. The 
expression pattern of IL-I ~ in PBLs following stimulation with either ConNPMA or 
LPS was carried out by real time PCR. We investigated the in vivo effects ofIL-I~ on the 
transcriptional program of Japanese flounder kidney by using cDNA microarrays to 
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obtain additional insights concerning the effect of this cytokine gene on the immune 
mechanism of Japanese flounder. 
2.2. MATERIALS AND METHODS 
2.2.1. Construction of cDNA library, screening and data analysis 
A cDNA library was constructed from the peripheral blood leucocytes (PBLs) 
collected from Japanese flounder. The PBLs were isolated by centrifugation at 400xg for 
20 min with Percoll solution density gradient (1.072 g/mL). The PBLs were cultured at 
25°C in RPM! 1640 medium containing LPS (500 ~g/mL) . mRNA was isolated from 
PBLs incubated in LPS after I, 3, and 6 h, using a micro mRNA purification kit 
(Amersham Biotech, U.S.A) following the manufacturer's instructions. The purified 
mRNAs of three different time periods were pooled and used to construct a cDNA 
library. The cDNA library was synthesized using the SUPERSCRIPT™ plasmid system 
(Life Technologies, U.S.A) following the instructions of the manufacaturer for cDNA 
synthesis and plasmid cloning. 
A partial cDNA clone of IL-I ~ was used as a DNA probe to screen a full length 
cDNA of IL-I~. The hybridization was conducted as previously reported.s The 
determined nucleotide and deduced amino acid sequences, and multiple sequence 
alignments were analyzed by GENETYX ver.8.0 (SOC Software Development, Japan). 
Phylogeny was inferred using the Clustal X and PHYLIP program, and by distance 
analysis using the neighbor joining method.9 The phylogenetic tree was generated using 
the Tree view software. The values supporting each node are derived from \00 re-
samplings. 
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2.2.2. Construction of plasmid expressing JF - lL-I ~ 
pGEM T-Easy vector (promega, Madison, WI, USA) ligated with the full length 
Japanese flounder interleukin-I~(JF-IL-I~) cDNA, was sub cloned into pCI-neo 
mammalian expression vector (promega, Madison, WI, USA) following the 
manufacturer's instructions. The plasmid was extracted by ultracentrifugation using a 
CsCI-ethidium bromide gradient. '0 
2.2.3. In vitro transcription I translation of JF-IL-l ~ 
The JF-IL-I ~ cDNA was analyzed 10 a TNT quick coupled 
transcription/translation system (Promega, Madison, WI, USA). One microgram of the 
plasmid DNA was added to the kit components following the manufacturer' s protocol. 
The reaction mixture was incubated at 30°C for 90 minutes and mixed with an equal 
volume of sodium dodecyl sulphate (SDS) buffer (125mM Tris hydrochloride,pH6.8, 
2%SDS, 10%glycerol and 5% 2-mercaptoethanol) and boi led for 5 minutes. A \o~l 
portion of the mixture was run on a SDS-15%polyacryladamide gel with a 5%stacking 
gel. The gel was electro blotted to a polyvinylidene difluoride (PVDF) membrane (Atto, 
Tokyo, Japan), bound with streptavidine-alkaline phosphatase solution and 
calorimetrically detected with western blue stabilized substrate for alkaline phosphatase 
(promega, Madison, WI, USA). 
2.2.4. Quantification ofIL-l ~ by real- time PCR 
The absolute copy number of the target transcript and standard curve for Japanese 
flounder IL-l~ and ~-actin were generated as described previously." Briefly, a cloned 
plasmid DNA for each sample was used to generate a standard curve. The cloned plasmid 
DNA (O.5J.1L) was used in 50~L of PCR mixture. The PCR primers used in real-time peR 
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are listed in Table. I. The PCR-reacted products were purified using Amicon Microcon-
PCR centrifugal filter devices (Millipore, USA).The copy number of reacted products 
were calculated according to the molecular weight of the products and then converted 
into the copy numbers based upon Avagadro's number ( I mol = 6.022 x 1023 molecules). 
Fifty microlitres of the PCR reaction was prepared for quantitative real-time PCR. The 
reaction mixture consisted of 5 ilL template DNA (10 llg/mL), 5 ilL of both forward and 
reverse primers (5 Ilm), 5 ilL 10 x SYBR PCR buffer, 6 ilL 25 mM MgCI2, 4 ilL dNTP 
blend (2 .5 mM dATP, 2.5 mM dCTP, 2.5 mM dGTP, 2.5 mM dUTP), 0.25 ilL AmpliTaq 
Gold (5 U/IlL), 0.5 ilL AmpErase UNG ( I U/IlL) and 19.25 ilL distilled water. The PCR 
amplification was performed as follows: I cycle at 50° C for 2 min and 95° C for 10 min. 
followed by 40 cycles at 95°C for IS s and 5SoC for 60 s. Thermal cycling and 
fluorescence detection was conducted using the Gene Amp 5700 sequence detection 
system as described above. All samples were run in triplicate with ~-actin as an internal 
positive control 12 and the normalization reference for individual variation. Statistical 
analysis of expression levels between different samples was analyzed by an independent 
student's t-test. Values were considered to be significant when P< 0.05. 
Table 1 Oligonucleotide primers used for real time PCR analysis 
Name 
IL-I Fst (Forward) 
IL-I Rst (Reverse) 
II-actin Fst (Forward) 
Il-aetin Rst (Reverse) 
IL-Ill Frt (Forward) 
[L-Ill Rrt (Reverse) 
Il-actin Fst (Forward) 
Il-actin Rst (Reverse) 
Sequenee(5'-3') 
5' -eet geteaaeateatgatga· 3' 
5' -aagaaetn geggt tgetge-3' 
5' -tnccetecallgttggteg-3' 
5' -gegaeteteagetegllgta-3' 
5' -cgtctccaccagatcagttcag-3 t 
5' -getgttetggaeeagaatgagt-3' 
5'-tgatgaageeeagageaga-3' 
5' -eteeatgtcateccagttggt -3' 
Infonnation 
Designed for making standard curve in 
realtime peR quantilative gene expression 
analysis of IL-l 13 and !l-aetin 
Designed for real time: peR analysis or 
IL-Ill and Il-aetin. 
2,2.5. Japanese flounder cDNA microarray construction 
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An 871 unique element Japanese flounder cDNA microarray was constructed 
based on the procedures described previously. I) Briefly, the preparation of the DNA chip 
was performed as follows. Individual Japanese flounder cDNA clones were carefully 
chosen to avoid duplication of the same genes from our previous EST analyses. cDNA 
clones from ESTs were used as template DNA and the primers (sense-
GTGCTGCAAGGCGA IT AAGlTGG, antisense- TCCGGCTCGT A TGlTGTGTGGA) 
were designed to anneal the vector region. The PCR was performed as follows. An initial 
denaturation at 95°C for 5 min, followed by 40 cycles of denaturation at 95°C for 30 sec, 
annealing at 55°C for 30 sec and elongation at 72°C for 2 min, and a final elongation step 
at 72°C for 5 min. The resulting PCR products were purified and concentrated by 96-
well PCR cleanup kit (Millipore, USA) to attain a final concentration above 500~g/mL. 
The purified PCR products were spotted on to the microarray slide by DNA Chip 
Research Inc, Tokyo, Japan. ~-actin genes were included on the array as controls for 
labeling, hybridization and fluorescent background 
2.2.6. Fish 
Thirty six Japanese flounder fish, each weighing about 109 were used in the 
study. The fish were maintained in recirculation sea water system at a constant 
temperature of 20°C. The fish were divided into two groups and intra-muscularly injected 
with 10~g ofpCMV-JF-IL-I~ or pCMV vector, respectively. 
2.2.7. RNA preparation for microarray analysis 
Total RNA was extracted from both pCMV-JF-IL-I~ and pCMV vector kidney 
tissue of Japanese flounder at I, 3, and 7 day post injection respectively, by TRIZOL 
reagent (Invitrogen Life technologies, USA) following the manufacturer's instructions. 
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mRNA was isolated from total RNA using Quick Prep micro mRNA purification 
kit (Amersham Biosciences, USA) according to the manufacturer's instructions. 
2.2.8. Preparation offluoreseently labeled eDNA, and hybridization 
One ~g of pooled mRNA isolated from pCMV-IL-I ~ induced fish and pCMV 
vector injected fish were labeled with CyS-amino-allyl dUTP and Cy3-amino-allyl dUTP, 
respectively, with a Labelstar array kit (Qiagen, USA) following the manufacturer's 
instructions. For final probe preparation, a sample containing equal amounts of Cy3- or 
CyS-labeled cONA was mixed with 7.5~L of hybridization buffer and IS ~L of 
formamide, transferred to the microarray glass slide, and incubated at 42°C for 18 h in a 
custom made slide chamber in which the humidity was maintained with few drops of 
distilled water. After hybridization, the arrays were washed with 2x SSC-O.I %SOS for 20 
min at room temperature, then washed with 0.2x SSC-O.I % SOS for 20 min at room 
temperature, washed twice with 0.2x SSC-O.I % SOS for 20 min at SSOC with gentle 
agitation, after rinsing with O.2x SSC-O.I % SOS at room temperature, the slides were 
dried and scanned immediately using a GenePix 4000B scanner (Axon Instruments, 
Foster City, California, USA). 
2.2.9. Signal detection and data analysis 
The fluorescent intensity for each dye (Cy3/CyS) was detected with a GenePix 
4000B microarray scanner. Images were analyzed by GenePix pro 3.0 software provided 
with the scanner. The signal intensity was normalized to the signal intensity of ~-actin by 
adjusting the PMT power and signal gain. Feature ratios of 2.0 and above was considered 
as up-regulation factor and 0.5 and below was considered as down regulation factor. 
S2 
GenePix Pro 3.0 displays the data in tables that can be exported to any standard spread 
sheet program. 
The nucleotide sequence reponed for Japanese flounder interleukin-I P in the 
present paper has been submitted to the GenBank database and has been assigned the 
accession number as follows : GenBank accession no. AB070835. 
2.2.10. Expression pattern of inducible genes in microarray analysis 
Expression pattern of inducible genes was analyzed by cluster 3.0 software 
(Eisen, 2003). 
2.3. RESULTS 
2.3.1. Cloning and analysis offulliength cDNA of JF-IL-IP 
The Japanese flounder (JF) IL-I P cDNA consisted of 1,329 bp. The translated 
open reading frame gave a predicted 247 amino acid precursor peptide with a molecular 
weight of 28 kDa (Fig. I ). The JF IL-I P cD A has six complete T A TIT A sequences and 
some other incomplete TATITA sequences in the 3'UTR (GenBank acc.No.AB070835). 
The identities of the deduced amino acid sequence of Japanese flounder IL-I p to other 
species. 11-\ ps ranging from 27% - 62% (Fig.2). Japanese flounder IL-\ p has highest 
peptide similarity (62%) with seabass, followed by trout with 52% similarity. The amino 
acid 
sequence alignment (Fig.2) showed a lack of aspartic acid residues in the region where 
ICE cuts the mammalian IL-I p precursor (Fig.2). Phylogenetic tree revealed that the 
Japanese flounder 11-1 p branches with sea bass and trout as nearest neighbors, and 
mammals are more distant neighbors (FigJ). 
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The molecular size of the Japanese flounder lnterleukin- I p (JF-IL-I ~) was 
analyzed by a coupled in vitro transcription-translation system. The presence of a major 
product of approximately 30 kD (Fig.4) corresponding to the pCMV -JF-IL-I P confirmed 
that a full -size protein was expressed from the cDNA clone. This was in close agreement 
with the calculated molecular mass of the JF-IL-I pat 28 kD. 
2.3.2. Quantitative gene expression analysis following stimulation of leueoeytes with 
ConAIPMA or LPS 
As shown in Fig.5, all stimulated leukocytes were significantly induced as 
compared to normal leukocytes. The expression of IL- I p mRNA was significantly 
enhanced after stimulation with ConAlPMA for I h and stimulation with LPS after 3h. 
2.3.3. Up or down regulation of genes in eDNA mieroarray analyses 
From the three arrays at 1,3 and 7 day post injection, a total of 93 (10.7%) of the 871 
tested genes were differentially expressed. Of the 871 tested genes, 61 known genes 
(7.0%) and 32 unknown genes (3.7%) were differentially regulated. A total of 64 genes 
or 7.4% were up-regulated and 29 genes or 3.3% were down regulated. The IL-IP -
induced genes were grouped into 7 clusters based on their functional characteristics. 
Cytokines, such as tumor necrosis factor (TNF), Granulocyte colony stimulating factor 
(G-CSF) and Chemokine receptor A, are included in cluster I. Cell surface antigens, 
such as MHC class I, IgM, CD20 are included in cluster 2. Cluster 3 is dominated by 
signal transduction genes, such as SH3P2, Toll like receptor. Apoptosis-related genes and 
inflammation-related genes are included in clusters 4 and cluster 5, respectively. 
Metabolism and other functionally regulated genes are included in cluster 6. The 
unknown/novel genes are grouped into cluster 7. Inducible cAMP early repressor and 
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glucocorticoid receptor genes were down regulated. The complete list of IL-I p-induced 
genes is presented in Table. 2. 
Fig. 1 
1 gctgaatcgagaacactcacagaacctcctctccactgactaccacagatctttcteeae 60 
61 tcagaaaaagatqgaatccaagatggaatgcaacgtgagccagatgtggagcgccaagat 120 
M E S K M E C N V S Q M W S A K M 
121 gccacagggactgaacttggagatctcccatcacccgatgacaatgagaagtgt9gtcaa 180 
P Q G L N LEI S H H P M T MRS V V N 
181 cctcatcatcgccatggagcggctgaagggcagccattcggaatctgtgctgagcacaag 240 
L I I A MER L K G S H S E S V L S T S 
241 cttcacagatgaaaacctgctcaacatcatgatggagaacatcgtgnaagagcacattgt 300 
F TOE N L L N I M MEN I V X E H I v 
301 gtgtgagagaagctcgtctccaccagatcagttcagcagaaggggcgtgtacacgtgcaa 360 
C E R S SSP PDQ F S R R G V Y TeN 
361 ca tcactgacagccagaagaggaacttcattctggtccagaacagcatggagctccacgc 420 
ITO S Q K R Nf l L VON S MEL H A 
421 cgtgatgctgcagggaggcagcagcaaccgcaaagttcttctcaacatgtccacctatgt 480 
v M L Q G G S S N R K V L L N M STY V 
481 gcacccttcacccaccatcgaagccaggcctgtcgttctgggcatcaaagacacagactt 540 
H P S P TIE A R P V V L G I K 0 TO r 
541 cttcctgtcatgccagaagaatggtgcagagccaaccctgcatctggagcgtgtcgagaa 600 
F L S C 0 K N G A E P T L H L E R V E N 
601 caaatgcgacctggaggcattcagcagggacagtgagatggtgcgatttctgttctacaa 660 
KeD LEA F S R D S E M V R F L F Y K 
661 gcaggacagcgggggggtgagcatcagcaccctcatgtcggcccgcttccccaactggta 720 
Q 0 S G G V SIS T L M S A R f P N W Y 
721 catcagcacatcagagcaagacaacaggccagtgatggtgggtcagaagaatgcccggtg 780 
1ST SEQ 0 N R P V M V G Q K N ARC 
781 ctaccagaccttcaacatccagcatcagagtt aaagccggccagaggggaacgtggatca 840 
Y Q T f N I Q H Q S 
841 gcatcttttcat ttttgagcctcaatctgcagctattttaattcaaataatcagtcagga 900 
901 agatgtaatttcaaaagaagcatcaccactgtctgctggaaagactttgagtgtctagtt 960 
961 actgtagtaccgagtacagagagaaaaatgcttagtgcattgacatagtcaagttttaca 1020 
1021 caaggtggcgttgttgagtagccagtgtatttcaaacagt tactgctttaatctatttat 1080 
1081 a~attatatatttatgtgtgtattt.aacatttgtgtttatttgggaatctgctt 1140 
1141 actaaaaattatttaa tgatatgcagcaaa tatttaaaaaaccttttcata ttctgtgtt 1200 
1201 gaatgtatgcttggagactgaaaaacaaaataagagtttcatcacatgctgtaaactgtg 1260 
1261 tttatttgctgtgtttatgacaataaacatcttgaatcttgaaaaaaaaaaaaaaaaaaa 1320 






































1 : -------------------------- --MESKMECNVSQMWSAKMPQGLNLEISHHPMTM 32 
1:----------------------------MESEMKCNMSEMWRSKMPQGLDLEITHHPLTM 32 
1 : --------- -------------MDfESNYSLIKNTSESAAWSSKLPQGLDLEVSHHPITM 38 
I:MACHEYVHQLDLSEAfETDSAIYSDSADSDELDCPDPQSMSCQCDMHDIKLELSSHPHSM 60 
1:-MALVPDLSSIPMEGYSGDDEMfYSDSPSGMKDDMEDAAQWQSSTSHCSLDIHVQITHGK 59 
1 : -MAFVPDLD--VLESSSLSEETFYG--PSCLC--LQKKPRLDSE- -HTTVDVQVTVRKGR 51 
1 : -----MAEVPELASEMMAYYSGNEDDLffEADGPKQMKCSFQDLDLCPLDGGIQLRISDH 55 
33 :RSVVNLIIAMERLKGSHSESVLSTSfTDENLLNIMMENIVXEHIVCERSSSPPD-----Q 87 
33:RRVVNLIIAMERLKGfSSETLMSTEfRDENLLNIMLESIVEEKIVfERGTTPTA-----Q 87 
39:RHIANLI-AMERLKGGEGVT-MGTEfKDKDLLNFLLESAVEEHIVLELESAPPASRRAAG 96 
61 :RQVVNIIIAVERLKHIKNMS--SGKfCDEELLGfILENVIEERLVKPLNETPI ------- 111 
60:GSLHSfRKAVVLVVAVEKL-KR--GKERffGDEDLLGLLDSIFVEEEIAfSQ-AKETHAS 115 
52 : GA-RSfRRAAVLVVAMTKLLRR-- PRSRDfADSDLSALLEEVf--EPVTFQR-LESSYAG 105 
56 : HYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFfPFlfEEEPlfFDTWDNEAYV H 115 
• 
88: FSRRG-VYTCNITDSQKRNFI----LVQNSMELHAVMLQGGSSNRKVLLNMSTY ---VHP 139 
88:YSKRR-EVQCSVTDSEKRSLV----LVPNSMELHAVMLQGGSDRCKVQLNMSTY---LDR 139 
97: FSSTS-QYECSVTDSENKCWV----LMNEAMELHAMMLQGGSSYHKVHLNLSSY---VT P 148 
112:YSKTSLTLQCTICDKYKKTMVQSNKLSDEPLHLKAVTLSAGAMQYKVQFSMSTf---VSS 168 
116 :ASTYRYQRATTCRIKDTSNKCFVMQKfHENAQLVALQLQGANIQREEKVSMAFY---ATQ 172 
106:APAFRYTRSQSFDIFDINQKCFVLES---PTQLVALHLQGPSSSQKVRLNIALYRPRGPR 162 
116: ~:VR~--SLNCTLRDSQQKSLVMSG~- -PYE~~:HL~~D~EQQ~FSMSFV~----Q 164 
140:SPT- IEARPVVLGIKDTDFFLSC-QK-NGAE-PTLHLERVENKCDLEAFSRDSEMVRFLF 195 
140:TPS-AEAQTVALGIKGTNYYLSC-HK-DGEE-PTLHLEVVD-KASLANITSDSDMVRfLF 194 
149:VPIETEARPVALGIKGSNLYLSC-SK-SGGR-PTLHLEEVADKDQLKSISQQSDMVRfLF 205 
169 :ATQ-KEAQPVCLGISNSNLYLAC-TQLDGSS-PVLILKEAS- - GSVNTlKAGDPNDSLLF 223 
173:PHQGGSKRPVALGLAGKNLYLSCRATEDGQDSPKLYLEEIS----NIKDVKGEDLNRFIF 228 
163: GSAGTGQMPVALGIKGYKLYMSC--VMSGTE-PTLQLEEAD----VMRDID SVELTRFIF 215 
165 : GEESNDKIPVALGLKEKNLYLSC--VLKDDK-PTLQLESVD----PKNYPKKKMEKRFVF 217 
... . . . 
196:YK--QDSGGVSISTLMSARFPNWYISTS--EQDNRPVMVGQKNAR-CYQTFNIQHQS--- 247 
195:YK--QDSG-LNISTLTSVPFSNWYISTA--EENNRPVQMCQESAR-RHRAFNIDNLKVDP 248 
206 :YR--RNTG-VDISTLESASFRNWFISTDMQQDYTKPVDMCQKAAPNRLTTfTIQRHN--- 259 
224 : FR--KETG-TRYNTFESVKYPGWF:STAFDDWEKVEMNQMPTTRTTNfTLEDQKRI---- 276 
229: MKSQDGLNETSTNSfESVAFPGWYISTSQRENELVQMVHQKNQEAIKDFNLFSVI----- 283 
216 :YR-LDSPTEGTTR-fESAAfPGWFICTSLQPRQPVGITNQPDQVNIATYKLSGR------ 267 
218:NK----IEINNKLEfESAQFPNWYI STSQAENMPVFLGGTKGGQDITDfTMQFVSS---- 269 
. . . .. . .. .... ... . 
Jflounder 247 :-------------












Human 269 : -------------
Fig.2 Alignment of Japanese flounder fL- f ~ with seabass, trout, carp, xenopus, chicken 
and human IL· f~ . Sequences were obtained from DDBJfEMBLlGenBank database. 
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Amino acids identical with Japanese flounder are shown by dots. The position of residues 
identical in all sequences are shown by asterisks. Gaps (dashes) have been placed to 
maximize identity. The ICE cut site (aspartic acid residue) in mammals is indicated with 
an arrow. 
2.4. DISCUSSION 
We determined the full length IL-I p cDNA sequence from a manne fish, 
Japanese flounder. Among previously reported fish IL-I p sequences in the databases, the 
one with the highest homology JF IL-I P is that of sea bass with 62% identity. JF IL-I P 
has multiple TATTTA motif sites in the 3' UTR, as is the case with other inflammatory 
molecules.14 This suggests that IF lL-1 P mRNA expression is tightly regulated. The 
presence of consensus sequence T A TTT A in the 3 'UTR of other fish IL-l ps 3-4 suggests 
that the regulation of mRNA stability is similar in other fish species. In mammals, IL-I P 
is produced as an inactive precursor that must be cleaved intracellularly by IL-I P 
converting enzyme (ICE). I; In contrast to this fish IL-I P precursors cloned to date lack a 
clear ICE cut site 4, and this also appears to be the case for the analyzed Japanese 
flounder cDNA sequence. 
Mitogen activation using ConAlPMA generates more lymphocyte clones than does 
antigenic LPS activation. This is because mitogens carry receptors with different antigen-
binding specificities and therefore activate more clones. In this study, PMA was used in 
combination with ConA because ConA and PMA are not mitogenic when used alone. 16 
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Fig.3 An unrooted phylogenetic tree showing the relationship between the full length 
Japanese flounder lL-I ~ amino acid sequence with other representative IL-I ~ sequences 
in different vertebrate groups. The tree was constructed by the neibour-joining method 
using the CLUST AL X and PHYLIP packages, and was bootstrapped 100 times. The 
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Fig.4 Translated protein of £L-I~. 
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Fig.S Quantitative real time PCR analysis of IL-I ~ expression in Japanese flounder 
following stimulation of PBLs with ConAlPMA or LPS at I, 3, and 6 hours intervals. 
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indicates up-regulation and green color indicates down-regulation of genes. 
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As expected, JF IL-I ~ was not found in the non stimulated leucocytes. In contrast, in gilt 
head seabream, IL-I ~ transcript was found in some of the tissuesn In our study, the 
maximum level of IL-I ~ was observed 3 h after LPS stimulation. Similarly, JL-I ~ 
expression in rainbow trout significantly increased between 2.5 and 4 hours after 
stimulation with LPSI8 Understanding the expression of immune response genes will 
help to characterize discasc-related inflammatory pathways and to identify thc functional 
properties of immune cell sUbpopulations. Therefore, an accurate quantification of 
mRNA expression is needed to assess differential gene expression. The greatest increase 
in the copy number of IL-I ~ mRNA was 30 fold after stimulation with ConAlPMA (Fig. 
3). 
In this study, we also focused on the gene expression pattern of immune-related 
genes of Japanese flounder kidney cells induced by lL-I ~ in vivo as kidney is the major 
lymphoid organ in fish and IL-I ~ is a potential inflammatory molecule. Tucker et al. 
reported detection of bombarded CAT (reporter gene) expression in fish of the CMV 
promoter group and fish of the SV -40 promoter group after plasmid DNA injection. The 
CAT expression in the fish group injected with CMV promoter was higher than that in 
the fish group injected with SV -40 promoter. 19 Kono et al. studied the IL-I ~ protein 
expression in serum on I, 3, and 5 days after pCMV -IL-I ~ plasmid injection.2o Therefore 
in this stdudy we used a CMV promoter -driven vector. 
The immune-related genes that were spotted on the microarray glass slide were 
related to inflammation, cell proliferation, signaling pathways, cell surface molecules, 
transcription factors and apoptosis. In our study, IL-I P induced gene expression was 
highest on day lover day 3 and day 7 after injection (Table.2). Our results are in 
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complete agreement with the findings of Kono et aI. , in which the expression of IL-l ~ 
was highest on day lover day 3 and day 5 after injection.2o The present results show that 
IL-l ~ induced the expression of Tumor necrosis factor (TN F), Granulocyte colony 
stimulating factor (G-CSF) and chemokine receptor A (Table. 2). A typical characteristic 
of IL-I~ is to synergize with a variety of cytokines including TNF and G-CSF. 
Synergism between IL-I~ and TNF has also observed in vivo21 Endotoxin or secondary 
mediators such as TNF, IL-l ~ and IFN-y are major stimulators of G-CSF production in 
vivo and result in rapid but transient elevation in serurn.22 Our results of IL-I ~-induced 
TNF and G-CSF in vivo agree with the findings of other research group. The induction of 
chemokine receptor A in our study indicates that IL-l ~ acts as a chemo attractant, as 
. I d 21 prevIOus y reporte . 
lL-1 ~ plays a central role in host defense. It induces differentiation and expression 
of surface immunoglobulin in pre B cells, proliferation of Th2 cells in combination with 
stimulation through the TCR, and proliferation and immunoglobulin secretion of mature 
B cells.24 Our finding that JF IL-I~ induced the expressions of IgM, CD20, ~-2-
microglobulin and the immunoglobulin light chain (Table. 2) suggests that it has a role in 
humoral immunity. CD20 also has a role in B cell activation and differentiation.2s The 
increase in the expression of MHC class I antigens in our study raises the possibility that 
IL-I ~ acts as a mediator of cellular immunity. This is because the adjuvant effect of lL-
I ~ requires increased cytotoxic lymphocyte activity26 CD3 gamma/delta plays a role in 
TCR complex assembly and in signal transduction mechanism.27 Surprisingly, CD3 
gamma/delta was down regulated in our experiment. 
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IL-I ~ in mammals is reported to be a signaling molecule for communication 
between the immune system and other internal systerns2 8 Toll-like receptor I (TLR-I), 
SH3P2, and Pleckstrin 47 were induced in response to IL-I~ in our study (Table. 2). 
TLR-I is expressed ubiquitously and at rather high levels. It associates with and regulates 
the TLR-2 response. TLR-2 activates the NF-kB pathway, which regulates cytokine 
expression through MyD88. Activation of the NF-kB pathway initiates the adaptive 
immune response by producing inflammatory cytokines such as lL-I , IL-6, IL-8 and IL-
12.29 SH3P2 protein (28 kDa) has a short praline-rich stretch and a SH3 domain at the 
amino terminus, followed by three ankyrin repeats. Proteins containing SH3 domains are 
essential in several well characterized signaling pathways, including the RaslMAPK 
pathway, which is involved in cellular division, differentiation and cytoskeleton 
reorganization in response to growth factor receptor activation. Interaction of SH3P2 with 
Cbl induced Src-rnediated tyrosine phosphorylation of SH3P2JO Transcription factors 
that activate IL-IP gene expression include NF-kB, AP-l and a tyrosine phosphorylated 
protein.J ) We believe that IL-l p-induced SH3P2 plays a role in tyrosine phosphorylation 
and MAPK signal transduction pathway. cAMP pathways are involved in regulating 
transcription of IL_lp.J2 cAMP inducing agents and IL-l itself have been shown to 
sustain m RNA levels for over 24 hours in human blood monocytes.Jl In this study, as 
expected, IL-IP down regulated inducible cAMP early repressor (Table. 2). 
IL-I P performs a variety of roles, acting sometimes as pro-apoptotis factor and 
some times as an anti-apoptosis factor. In the latter case, it protects against TNF-
mediated cell death by arresting cell cycling.J4 IL-\ is processed and released during 
apoptosisJS Cytochrome c oxidase is a pro apoptosis molecule. Several apoptotic 
6S 
pathways release cytochrome c from the mitochondrial intermembrane space, resulting in 
the activation of downstream caspases.36 IRF4 activates the basal transcription of IL-l 
beta promoter in macrophages and fibroblasts 31 and is essential for the function of B 
cells and cytotoxic T lymphocytes]8 Cathepsin B has different roles. It protects cytotoxic 
lymphocytes from self destruction after degranulation39 TRAFl5 is an apoptosis-related 
protein according to entries in the databases. Cytochrome b is an essential component of 
the super oxide-generating oxidase.4o Our results seem to show that IL-l ~ activates both 
pro and anti apoptosis molecules. 
Many other genes with different functions were also induced in response to IL-\~, 
such as matrix metalloproteinases (MMP) (e.g. , gelatinase) and oxidative 
phosphorylation-related NADH dehydrogenases. MMP genes are strongly induced by IL-
1~7 IL-l has been shown to up-regulate monocyte and macrophage MMP (gelatinase) 
production in vitro.41 As expected, the glucocorticoid receptor was down regulated in our 
study (Table. 2). Corticosteroids inhibit the transcription of IL-\. Increased synthesis of 
IkB with decreased translocation of NF-kB is thought to account for the suppressive 
effect of glucocorticoids on cytokine synthesis.42 Some unknown genes were up or down 
regulated in our experiment. In our previous EST analyses 35-40% of the genes were 
unknown genes which did not show any homology to the known genes in the gene bank 
databases. Some of these genes are expected to have immune function. The nucleotide 
sequencing and protein expression patterns are expected to give more complete 
information about these genes. 
In conclusion, our results demonstrate that the immune response in Japanese 
flounder is significantly influenced by IL-\~, both in vitro and in vivo. The fish injected 
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with IL-I P cDNA using a DNA injection method stimulated the expression of immune 
related genes, suggesting that Japanese flounder IL-I p gene has functional similarity with 
that of mammalian IL-I p. Dissociation between transcription and translation is 
characteristic of IL- \p'43 The microarray analysis made it possible to identify these 
immune responses at the transcriptional level. Further studies are needed to understand 
the changes at the translational level. 
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Chapter 3 
Adjuvant effects ofIL-IP, IL-8 homologue and JFCCI 
on DNA vaccination against viral hemorrhagic 
septicemia (VHS) in Japanese flounder (Paralichthys 
olivaceus) and analysis of chemokines (IL-8, JFCCl) 
immune response using cDNA microarrays 
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ABSTRA CT: Three fish cytokine genes (IL-I~, IL-8 and ]fCC I) were evaluated for their 
adjuvant effect on a suboptimal dose of viral hemorrhagic septicemia virus DNA vaccine 
carrying the glycoprotein gene (VHS g) in Japanese flounder, Paralichthys olivaceus. 
Fish were intramuscularly injected with 0.1 ~g of VHS g vaccine plus a I 0 ~g of 
cytokine expression plasmid. Experimental challenge of I X 103 TCIDso virus eight days 
post-vaccination revealed that the adjuvants used in this study were able to provide 
significant protective immunity against VHS and this lasted until 21 days after challenge. 
The adjuvant vaccines had a high protective efficiency, giving relative percentage 
survival (RPS) values of at least 70 percent. The defense mechanisms activated by two of 
the cytokines (IL-8, JFCC I) were further elucidated by microarray analysis. IL-8 up-
regulated specific immune-related genes such as Ig M, Ig D, MHC class IA and T cell 
receptor ~ at I day post-injection. JFCCI up-regulated non-specific and specific immune-
related genes such as IL-8, CC chemokine receptor A, lysozyme, Ig M and ~2-
microglobulin. Our results confirm that the adjuvants elicit strong humoral and cellular 
immune responses which may play a pivotal role in protecting the fish during virus 
infections. 
KEYWORDS: Japanese flounder; Viral haemorrhagic septicemia virus (VHSV); 




Viral hemorrhagic septicemia virus (VHSV) is the most serious viral pathogen 
affecting fresh water and marine species.' In 1999, VHSV infection occurred in wild 
Japanese flounder, Paralichthys olivaceus, in Japan2 Recently, novel vaccination 
strategies using antigen-encoding DNA plasmids have been shown to successfully induce 
protective cellular and humoral immune responses against a variety of infectious diseases 
in fish, including VHSV in Japanese f1ounder.3 Various strategies have been used to 
increase the efficiency of DNA vaccination. For example, immune responses induced by 
DNA vaccination can be enhanced by co-injection with recombinant cytokines or 
plasmids encoding these cytokines.4 
Utilization of cytokines as adjuvants for fish viral diseases is becoming more 
feasible as fish homologues of mammalian cytokine genes become available. S Several 
Japanese flounder genes homologous to mammalian cytokines have been cloned 
including IL_l~,6 [L-S7 and CC chemokines.8 Recently we constructed a cDNA chip that 
contains approximately 900 different cDNA clones including 91 immune-related genes.9 
Microarrays can be used to study the response of a host to challenge with the stimulant 
such as cytokine and identify immune gene responses.' o A microarray can be a useful 
tool for quantitatively analyzing the expression of innate, humoral and cellular immune-
related molecules following DNA vaccine and expression plasmid injection in fishes. 3. 6 
In the present study, a panel of plasmids expressing three cytokine genes, Viz. IL-
I~, IL-S homologue and JFCC I of Japanese flounder, were evaluated for adjuvant effect 
on vaccination with a recombinant plasmid expressing the VHSV glycoprotein gene in 
Japanese flounder. Using microarray analysis, we studied the expression profile of genes 
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that are responsible for non-specific and specific immune responses at I, 3 and 7 days 
following injection ofIL-8 homologue and JFCC 1 expression plasm ids. 
3.2. MA TERlALS AND METHODS 
3.2.1. Cells and virus 
VHSV-KRRV strain 9822, which was isolated from farmed Japanese flounder in 
Kagawa prefecture in Japan, I I was kindly provided by Dr. T. lsshiki of the Kagawa 
Prefectural Fisheries Experimental Station. The virus was propagated in hirame natural 
embryo (HINAE) cellline. 12 For virus propagation, HINAE cells were infected with virus 
and incubated until a cytopathic effect (CPE) was observed. The supernatant was 
collected by centrifugation at 2500 X g for 5 min and stored in I-ml aliquots at -80 °C 
until use. 
3.2.2. Construction of recombinant pCMV -VHSg vaccine and cytokine expression 
plasm ids 
pCMV -VHSg vaccine] was constructed by cloning the VHS glycoprotein gene 
into the pCDNA 3.1(+) expression plasmid (Invitrogen, USA). The pCMV-lL-IP 
expression plasmid was cloned into pCI-neo mammalian expression vector (Promega, 
Madison, WI, USA) as described earlier.6 cDNAs for a full-length Japanese flounder IL-
8 homologue and JFCC I were cloned into pCI-neo mammalian expression vector 
(promega, Madison, WI, USA) following the manufacturer's instructions, and named 
pCMV -IL-8 and pCMV -JFCC I respectively. The expression plasmids were extracted by 
ultracentrifugation using a CsCI-ethidium bromide gradient. I ] 
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3.2.3. Vaccination with pCMV-VHSg and cytokine expression plasm ids 
Japanese flounder juveniles weighing approximately 3 g were given 50 ~I 
intramuscular injections containing 0.1 iJg and I iJg of pCMV -VHSg plus I 0 ~g cytokine 
gene plasmids in phosphate buffered saline (PBS). Fish in the negative control group 
were each injected with 50 ~I PBS. The positive controls were injected with pCMV -VHS 
g (0.1 ~g and I iJg) or cytokine expression plasmids (I 0 ~g) alone. The fish were fed daily 
and the water temperature was kept at 12-13 °c in a re-circulated water system. 
3.2.4. Sampling 
Kidney tissue was collected from six fish from each of the three groups (IL-8 
homologue group, JFCCI group and empty vector group) at 1, 3 and 7 days post-
immunization and stored at -80 °C until total RNA extraction for microarray analysis. 
3.2.5. Challenge experiments 
Eight days after vaccination, fish were experimentally challenged with VHSV by 
intraperitoneal injection. Thirty fish from each group were given a dose of I X 103 
TCIDso . Cumulative mortality was monitored daily over a three-week period. 
3.2.6. Statistical analysis 
Differences between the experimental and control groups were analyzed by X2 
test with Yates' correction. Relative percentage survival (RPS) was determined by the 
formula RPS = (1- % mortality of vaccinated fish! % mortality of control fish) X 100. 14 
3.2.7. Microarray analysis 
The cDNA microarray chip used in this study contained a total of 871 clones 
consisting of91 immune-related genes, 371 genes of unknown function and 409 genes of 
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metabolism-related and housekeeping genes9 Each gene was spotted in duplicate to 
facilitate comparison during the analysis . 
Total RNA was isolated from kidney cells from six fish in each of the three 
groups at 1, 3 and 7 days post-immunization using Trizol (Invitrogen Life technologies, 
USA). A sample of total RNA sample (50).lg) from each group was synthesized into 
cDNA using a Labelstar Array Kit (Qiagen, Japan) and the purified cDNAs were labeled 
with Cy3 or Cy5-dCTP using a Cyscribe First-Strand cDNA Labeling Kit (Amersham 
Biosciences, USA) following the manufacturer' s instructions. The arrayed clones were 
hybridized with an equal volume of Cy3- or Cy5-labeled first strand cDNA in 
hybridization buffer. Hybridization was carried out at 42 °C for 18 h. After 18 h, washing 
was performed with 2X SSC-O.I % SDS for 20 min at room temperature, 0.2X SSC-O. I % 
SDS for 20 min at room temperature, two washes 0.2X SSC-O.! % SDS for 20 min at 55 
°c with shaking, followed by a rinse with 0.2X SSC-O. I % SDS at room temperature. The 
glass slides were dried and scanned immediately using a GenePix 4000B scanner (Axon 
Instruments, USA). 
Images obtained from scanning were analyzed by GenePix Pro ver.4.0 software 
(Axon Instruments, USA). Cy3 and Cy5 signal intensities were normalized to the signal 
intensity of the spoued housekeeping gene (p-actin) by adjusting the PMT power and 
signal gain. The signal intensity was calculated as the mean intensity of duplicate spots 
minus the background signal. The feature ratio was calculated from the stimulated sample 
signal intensity divided by the control signal intensity. Genes with feature ratios over 2.0 
were considered as up-regulated and genes with feature ratios less than 0.5 were 
considered as down-regulated. 
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3.2.8. Conventional RT-PCR 
Total RNA (2.5~g) from the same sample used for the microarray was reverse 
transcribed to cDNA with an AMV reverse transcriptase fi rst-strand cDNA synthesis kit 
(Life Sciences, USA). PCR was performed following initial denaturation at 95 DC for 5 
min, followed by 30 cycles of denaturation at 95 DC for 30 s, annealing at 55 DC for 30 s, 
and elongation at 72 DC for I min, and a final extension step at 72 DC for 5 min. The 
primers used are given in Table.1. The PCR products were electrophoresed and 
visualized in a 1.5% agarose gel using a densitometer (A TID Co., Japan). 
Table.l Primers used in RT -PCR analysis 




il-actin 5'-TGATGAAGCCCAGAGCAAGA-3' 5'-CTCCATGTCA TCCCAGTTGG-3' 
IL-8 5'-ATCGTTGTTGCfGTGATGGTG-3' 5'-CTCTT AA TGTAGCGGCCGATG-3' 
TCR-P 5'-GCACCATTCACACACfGTGGTT-3'5'-AACAGGCfGGTTTGTGAGCfG-3 





Expression pattern of inducible genes in microarray analysis was analyzed by Cluster 3.0 
software. 
3.3. RESULTS 
3.3.1. Effect of pCMV-VHS g vaccine co-injected with cytokine genes against VHS 
virus 
The cumulative mortality of the VHS g-vaccinated group (1) following challenge with I 
X 103 TClDlo virus concentration was 48% compared with 23-30% mortality for the 
adjuvant-vaccinated groups (II, HI and IV). On the other hand, 100% of PBS-injected fish 
(group IX) and 90-93% of the cytokine expression plasmid-injected fi sh (groups V, Vl, 
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and VII) died following the viral challenge (Fig. I ). On the other hand, no adjuvant effect 
was observed in I ~g VHS g vaccine (Fig.2). 
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Fig.1 Cumulative mortali ty of adjuvant vaccinated Japanese flounder challenged with I 
X lOJ TClDlo VHSV lfish . Fish were vaccinated by intramuscular injection and virus 
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Fig.2 Cumulative mortality of adjuvant vaccinated Japanese flounder challenged with I 
X 10J TCID50 VHSV/fish . Fish were vaccinated by intramuscular injection and virus 
challenge was performed eight days post-vaccination by intraperitoneal injection. 
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As shown in Table.2 the relative percentage survival (RPS) obtained in the VHS 
g-vaccinated group (1) was 52%; whereas, the adjuvant-vaccinated groups (II, ill and IV) 
had values of 70-77% RPS. The RPS obtained in the cytokine expression plasmid groups 
(,/, VI and VII) was only 7-1 0% Vs 0% survival in the PBS-injected fish (IX). The 
Adjuvant-vaccinated groups displayed signi ficantly enhanced survival rates relative to 
the VHS g-vaccinated group (Table.2). No signi ficant difference was noted in the 
survival rates among the cytokine expression plasmid groups (Table.2). The RPS values 
of adjuvants in I I1g VHS g group (VI, VII, VIIl) did not exceed the RPS values of VHS 
g vaccine I I1g ('/)a1one (Table.2) . 
Table.2 
Experimental group !1x103 TCID SOl fish ! 
Adjuvants treatment Dead flshlvacc lnated (dead flsh%) RPS 1l 
I. pCMV-VHSg (0.1119) 
+-
14/29 (48%) 52 18.1 6 
II. pCMV-IL-1~ (10119)+pCMV-VHSg (0.1119) 7/30 (23%) 77 34. 12 
III. pCMV-CXC chemokine (10I19)+pCMV-VHSg (0.1119) 7/30 (23%) 77 34.12 
rv. pCMV-MIP-1a (10I19)+pCMV-VHSg (0.1119) 9/30 (30%) 70 29.3 
V. pCMV-VHSg (1119) 4/30 (13%) 87 42.42 
V I. pCMV-IL-1~ (10I19)+pCMV-VHSg (1119) 10/30 (33%) 67 27.07 
VII. pCMV-CXC chemokine (10119)+pCMV-VHSg (1119) 6/30 (20%) 80 36.73 
VIII. pCMV-MIP-1a (10I19)+pCMV-VHSg (1119) 5/30 (1 7% ) 83 39.49 
IX pCMV-IL-1~ (10~g) 27/30 (90%) 10 N.S 
X pCMV-CXC chemokine (10~g) 28/30 (93%) 7 N.S 
XI. pCMV-MIP-1a (10119) 30/30 (100%) 0 N.S 
XI I. PBS 30/30 (100%) 0 -
Table.2 Cumulative percentage mortalities and calculated RPS values following 
challenge with VHSV. 
3.3.2. Expression of immune-related genes in kidney cells following IL-8 expression 
plasmid injection 
Several genes were highly expressed 1 day after expression plasmid injection in 
the /L-8 group (Table.3). These were grouped into humoral immunity, cellular immunity, 
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other immune-related genes, metabolism-related genes and unknown genes. Some of the 
important genes that were highly expressed were 19 M, Ig D, MHC class lA, T-cell 
receptor ~ (TCR ~) and transcription factor BTF3 . The expressions of a number of genes 
in !L-8-induced kidney cells changed at different times after expression plasmid injection 
(Table.4). The greatest number of genes with changed expression levels (32; 3.7%) was 
observed I day after plasmid injection. 
3.3.3. RT -PCR analysis of IL-S- inducible genes 
The expression of TCR ~ greatly increased at I day after IL-8 plasmid injection 
(FigJ), which strongly supports the results of microarray. 
3.3.4. Expression pattern of IL-S inducible genes 
The expression of inducible genes was high on the I day followed by 3 day and 7 
day (Fig.4). 
3.3.5. Expression of immune- related genes in kidney cells following JFCCI 
expression plasmid injection 
Several genes were highly expressed 3 day after expression plasmid injection in 
the JFCC I group (Table.S). The genes were grouped into innate immunity, humoral 
immunity, other immune-related genes, metabolism-related genes and unknown genes. 
Some of the important genes that were highly expressed were IL-8, Ig M, Complement 
component C3 and Lysozyme II. The greatest number of genes with changed expression 
levels (36; 4.1 %) was observed I day after plasmid injection (Table.6). 
3.3.6. RT-PCR analysis of JFCCl- inducible genes 
The expression of !L-8 greatly increased at 3 days after JFCC 1 plasmid injection 
(Fig.5), which strongly supports the results of microarray. 
84 
Fig.3 
1d 3d 7d 
1 2 3 4 5 6 
TCR~ 
~-actin 
Fig.3 RT-PCR analysis of IL-8 inducible genes of Japanese flounder kidney cells in 
microarray. (A) TCR-P (8) p-actin. Expression of inducible genes on 1, 3 and 7 days 
after pCMV -IL-8 intramuscular injection ( lanes I, 3 and 5) and empty vector alone ( 
lanes 2, 4 and 6). 
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Table: 3 Transcriptional profile of Japanese flounder kidney cells induced by IL-8 
Grouj! Gene 10 t\ct.No. Gene Name EX l!rtsSioll 
I da~ 3 da~ 7 da~ 
Humoral immunity X43 AU260744 IS M 2.9 1.1 0.8 
K49 AU260450 ISO 2.1 0.9 0.9 
Ceflular immunity WH6·20F AU050612 MHC c\asslA 2.1 NO 0.8 
026 AU260532 T-ctll rcccEtor ~ 2.1 NO NO 
Other immune related genes WE9-\3F AU050269 Heal shock factor binding protein I 2.1 0.6 0.7 
WFI2(1) CSI99 1 Hsc70 2.1 I 
OLIO BAAS9039 Cytochrome oxidase subunit-) 2 1.1 NO 
B954 AU091 153 Transcription factor BTF3 2 1.3 O.S 
LG3(6) C232S0,C232S I Apolipoprotein A-I OJ 2 NO 
a LII BAAS9045 ~ochrome-b 1.1 0.4 0.7 
Metabolism rolated genes WC 1\-17F AU050462 Ribosomal protein LS lJ NO NO 
WG5(2) CS2058 Pmtea50me subunit Z 2J NO NO 
LB6(5) C231S0 Glycine decarboxylase 2.1 NO 0 
WOS-15 AU050338 Nbrl 2.1 NO NO 
B900 AU09II33 Elongation factorly 2 1.1 NO 
OL47 Q9IA79 Probable Sax inhibotor-I 2 NO NO 
VIOS AU260703 Mast cell protease 3 (SMCP-3) 2 NO 1 
WGII (5) CS2261.C82262 Auxilin 2 NO NO 
WC4(2) CS2026 DdGPK2 2 NO 0 
V35 AU26066 I L-Iactate dehydrogenase M chain 0 .• NO NO 
OL32 BAA89040 NAOH dehydrogenase subunit-) I 0.5 NO 
1.2 AU260861 Ribosomal prolein L J 2 I 0.5 0.7 
L353 AU261112 l-plastin 0.9 0.5 0.8 
L152 AU260995 Low mol.Wt.Hsp30B 0.5 NO 
L2 17 AU261026 Syntaxin binding protein 3 0.9 0,5 0.7 
YI34 AU260S48 Heparin 0.9 0.4 0.7 
L72 AU260937 Limulin 0.4 NO 
Y77 AU260807 Elongation factorl-a I 0.4 NO 
Y45 AU260781 Ubiquitin A-52 residue ribosomal protein O.S 0.4 0.7 
L211 AU26 1024 265 proteasome regulatory chain 12 I 0.4 NO 
Y50 AU260784 Human Elatelet Erofilin I 0.9 0.4 0.7 
Unknown genes HC5(1) C23494,C23495 unkno"'ll 2.9 NO NO 
WG6-8R AU050069 unknO\\ll 2.7 NO NO 
jIXOOI 7/f AU260427 unknown 2.5 NO NO 
Y63 AU260794 unknown 2.4 NO NO 
HC6(1 ) C23496,C23497 unknown 2.4 NO NO 
WEl(5) CS2254 unknown 2.3 1.1 0.7 
BIISI AU09 1252 unknown 2J NO NO 
WH7-8R AU050073 unknown 2.2 1.1 0.9 
LB9(8) C23335 unknown 2.2 NO NO 
9509 AU090975 unknown 2.1 NO NO 
WD9-16F AU050397 unknown 2 NO NO 
L51 AU260920 unknown 2 0.9 0.7 
LI45 AU260990 unknO\'ol1 O.S 0.5 0.7 
B8S6 AU091124 unknown 0.5 0.7 
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Table.4 summary of microarray-based analysis of IL-8 inducible Japanese flounder 
kidney cells. 
Class of genes Number 






Unknown genes 371 
Days after pCMV-IL8 plasmid injection 1 day 3day I 7day I 
UI>-regulated gene~_ 
-- -
- I- - - -
Known 18 1 a 
Unknown 12 a 0 
Total 30 1 0 
Down-regulated genes 
Known 2 11 a 
-
- I--- -Unknown a 2 a 
Total 2 13 a 
Total number of differentially expressed genes 32 14 H Percentage(%) of differentially expressed genes I 3.7 1.6 I 
Table.6 summary of microarray-based analysis of JFCC I inducible Japanese flounder 
kidney ceLIs. 
Class of genes Number 




Unknown genes 371 
Days after pCMV-JFCC1 plasmid injection i 1day I 3day I 7day 
U!>-Tegulated genes 
---j-r 1 1 -Known 27 6 1 Unknown - - t 6 I 2 Total 14 33 8 
Down-regulated genes I 
Known 1 1 1 
-Unknown 1 2 1 
-Total 2 3 2 
Total number of differentially expressed genes 16 36 10 
Percentage(%) of differentially expressed genes 1.8 4.1 1.1 
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Table.5 Transcriptional profile of JFCC 1 induced Japanese flounder kidney cells. 
GroUI! G~nem Gent Ite.No. GUt ... me EIl:!rtsS~. 
I da:£ 3 da:i 7 da:i 
inMft immunity WOS(S) CS225{).CS12S I TNFR I 0.5 OS NO 
BIISJ AU091230 exc chemokmc vlL8 1.1 NO 
cc c:hemoR A Not reponed CC chemokine receptor A 2 0.9 
LB3(10) C23436 complement component C3 3.3 NO NO 
II 2.1 
LY·6G I 0.9 2.1 
BS66 AU091110 protem AA I ) 17 65 
WB2(4) CS2 161 translatIOnal regulatory fac tor NACIJ 92 I I 2.4 I 5 
LJ74 AU26 I DOS dnaK-type molecular chaperone 1.1 2.4 14 
WG2·IIR AU05{)193 (Apoptosis-relaled protein TFARIS) O.S 1.3 1.3 
LG3(6) Cl3280.C2328 I apolipoproltin A-I 3.9 0.6 0.3 
OLS9 BABS3S2S TBT-blinding protein 3.8 NO NO 
LAS(I) Cl3DOI transrerrin 3.4 0.7 0.' 
L201 AU261020 KIM 1 S32 protein 2.3 I.J 
L07(2l C2J063 8e!!lie2Erotein E 1.2 2.2 I 
Metabolism re/aled gents LAI2(S) C23I7S prechymotrypsinogcn 3.1 NO NO 
LFI(4) C23IS7 uypsin 2.4 NO NO 
LE2(6) C2326S fibrinogen alpha subunit 2.3 NO NO 
OL30 BAAS9033 NADH dehydrogenase subumI-1 2 1.1 
LJI7 AU261 0S2 Ketohexokinase 1.1 2.4 1.4 
Y37 AU26077S (AKOO5 147) putative 2.3 1.1 
B314 AU090867 Hypothetical 18K prolein 1.1 1.3 I.S 
YSO AU260SI 0 mRNA for ribosomal protein 59 1.1 2.3 
Y3 AU2607S0 60S ribosomal protem L27 A or L22 1.2 2.3 1.2 
WCS· 14R AUOS0279 cysteine-rich intestinal protein 1.2 2.2 I 
LI23 AU26097S Gene HMO-T2 protein 1.1 2.2 1.2 
LJ94 AU261132 405 ribosomal prolein S ISA 1.6 l .l 25 
K29 AU260434 40S ribosomal protem 53 1.4 2.2 1.2 
LB9(I) Cl3011 ribosomal protem 53 I' 1.1 I.J 
LHS(I) C230S0 285 ribosomal RNA 0.9 1.1 1.4 
L211 AU261024 265 proteasome regulo.tory chain 0.9 2 1.4 
V3S AU26066 I L-Iactate dehydrogenase M chain 0.8 2 I.J 
WES-SR AUOSDOS3 myosin-IA I.J 2 1.3 
BS8S AU091123 605 ribosomal protein L21 O.S 2 NO 
Y137 AU260SS I 405 ribosomal protem 20S protem 1.2 2 1.1 
YI26 AU260S40 Histone HI 0.9 0.2 O.S 
B710 AU09 1037 MCIS2R 0.7 1.9 4.1 
WEII(I ) CS19S0.CS1981 ribosomal protein 517 0.9 I 3 1.7 
WB7-12F. -I 2 AU05{)220 do(!!!!!in ftte~tor 018, nk 0.8 1.1 2.2 
Unknown gtnu LG2(1O) C23474 uk 4.2 NO NO 
LD4(S) C23 I 96. C2Jl97 uk 4.1 NO NO 
LBJ(7) C23294 uk 3.6 NO NO 
LOIO( I) C23023 uk 3.2 NO NO 
LE10(4) C23ISS. C23IS6 uk 2.4 NO NO 
LEI 1(9) C23402 uk 2.4 NO NO 
K40 AU260442 uk 0.4 NO NO 
BII7 AU090736 uk NO 5.7 NO 
WGS-19F AU05{)S60 uk 0.9 2.4 NO 
L26S AU261055 uk 1.2 2.3 1.4 
L274 AU261 0SS uk I.S 2.2 I.) 
L16S AU26 I 005 uk 2.1 1.1 
8610 AU09IDOS uk 2.1 1.4 
LGI O(S) 0)225, C23226 uk 07 0 •• NO 
LBJ(S) C2333 I uk 00 0.2 NO 
Z23 AU260878 uk I 1.6 2.S 
LE3(S) C2J206, C23207 uk 0.6 19 2. 1 
LC4(1l C2329S uk NO NO 0.3 
gg 
Fig.4 Expression pattern of IL-8 inducible genes 
LG3t6l Rao1~~ODrotei~ A-I 
"HE9-1.3F "".a."t shock. 1:a..ctor b:Ln.d.in.g- protein. ::L 
B954 T:r~cr~Dtion. 1:acto:r BTF3 
"til!" 1.2 I 1. ) J-«8c --, 0 
V1.08 ~t ce11 ~rotea&e 3 (SMCP-3) 
~6-2~C c1assIA 
o:L:10 Cvtochrc:Dl1lle ox::l..d..a..Be _ub~ t -:3 
B900 E::Luna.a."tiun ~actor::L? 
~4 I 2) DdGP'R2 
'HG-1.1. I ~) Aux::i.1:in 
OL4 --, Probab1e Bax inhibotor-1. 
"WI> 8 -1.~ :Nbr 1. 
LB 6 I ~) G1:yc:ine decarJ:>oxy1ase 
X43 I.,,- M 










'HG-~ I 2) Proteas........ _uJ:>un:i. t z 






OL32 HADH dehvdroc:orenase s uJ:>un:i.t-3 
Z 2 RibOBc:ona.1 "Drotein. L 1.2 
L 1.~ 2 LOVO'" :rno1. "Oft. _ HSp 3 OS 
L --, 2 L:I.:aRu1:in 
Y~7 E1o~ation. 1:actor1-a 
L2::L::L 265 ~rotea.ume regu1atory chain :1.2 
B886~ 
L::I 5 3 L --u1a.-t:i.. ... 
Y1.34 ~a.r:i..n. 
Y50 H~ "D1ate1et "Dro~i1in. I 
L217 S~taxin bindina "Drotein. 3 
Y45 Ubiuuitin. A-52 residue r1bosc:ona.1 protein 




1d 3d 7d 
1 2 3 4 5 6 
IL-8 
~-actin -
- - - ..... '!;......- , " ""-" - - - -- - - ~ ... 
Fig.S RT-PCR analysis of JFCCI inducible genes of Japanese flounder kidney cells. 
(A) IL-8 (JD name:BI153), (B) ~-actin . Expression of inducible genes on 1,3 and 7 days 
after plasmid injection with pCMV -JFCC I (lanes I, 3 and 5) and empty vector alone 
(lanes 2, 4 and 6) 
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Fig. 6 Expression pattern of ITCC I inducible genes 
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3.4. DISCUSSION 
Applications of DNA vaccines in aquaculture have been reported. IS The use of 
expression plasmids for certain cytokines or co-stimulatory facto rs enhanced the immune 
responses induced with a DNA vaccine.16•17 In this study, Japanese flounder fish 
vaccinated with 0.1 ~g of pCMV -VHS g vaccine encoding the glycoprotein gene showed 
significant protection against VHS virus (52% survival). Co-administration of 1L-1~, 1L-
8 and JFCC I adjuvants with pCMV -VHS g vaccine significantly enhanced the survival 
rates of fish compared with fish given the pCMV -VHS g alone (Table.2). 
We previously showed that the pCMV-VHS g vaccine had high protection 
efficiency, giving relative percentage survival values (RPS) of 93% with 10 ~g of 
plasmid DNA.J However, a sub-optimal dose of vaccine antigen co-injected with 
cytokines proved valuable in assessing the adjuvant effects of cytokine genes. IS 10 this 
report, a suboptimal dose of 0.1 ~g of pCMV -VHS g vaccine was chosen in order to 
maximize the effect produced by co-injection of IL-I~ , IL-8 and JFCC I cytokine genes 
(I 0 ~g). Although the results depended on the DNA dose and genetic background of the 
host, they indicate that an adjuvant effect is elicited by co-injection oflL-1 ~, 1L-8 and 
JFCCI with pCMV-VHS g vaccine (Fig.1 & Table.2). Co-injection of these genes (10 
~g) with I ~g of pCMV -VHS g did not result in significantly higher survival rates than 
were obtained with DNA vaccine alone (Fig.2 & Table.2). Injection of the cytokine genes 
in the absence of the pCMV -VHS g did not elicit similar responses, indicating that the 
cytokines were acting as adjuvants rather than immunogens (Fig. I & Table.2). These 
results agreed with the results of previous study IS in which different cytokine genes were 
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used as adjuvants and immunogens to develop a vaccine against a protozoan infection in 
chickens. 
The expression and immune responses following the injection of plasmid DNA 
containing the IL-I ~ 19 and a novel CC chemokine molecule 20 with the CMY promoter 
sequence in fishes have been reported. Fish injected with the CAT gene under the control 
of the CMV promoter showed high CAT expression21 In a microarray analysis of 
Japanese flounder kidney cells,6 we showed that genes up-regulated by IL-I~ were most 
strongly expressed on I day followed by 3 day and 7 day after plasmid injection. In the 
present study, we found that up-regulation of genes induced by IL-8 homologue in 
Japanese flounder kidney cells was highest on day I and that up-regulation of genes 
induced by ITCC I was highest on day 3. This indicates that production of pro-
inflammatory proteins such as IL-I~ , IL-8 and JFCC I was higher in the early stages after 
immunization. Other groupSl9.20 also reported higher production of pro-inflammatory 
proteins in fishes in the early stages after immunization with pCMV -Ill ~ and a novel 
pCMY- CC chemokine. 
IL-8 has been reported to attract T cells in vitro and in vivo.22 Our microarray 
results of IL-8 induced kidney cells, up-regulated specific immune-related molecules 
such as MHC class IA and T cell receptor ~ suggesting that JL-8 is an activator of T cells. 
MIP-Ia is a more potent chemoattractant with a broader specificity, attracting B cells and 
cytotoxic T cells as well as CD4+ T cells.23•24 Our microarray results showed that 
ITCC I (MIP-I a), induced innate, humoral and cellular immunity-related molecules such 
as IL-8, CC chemokine receptor A, complement component C3, Ig M and ~2-
microglobulin. This observation suggests that the function of fi sh JFCC I is similar to the 
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function of its mammalian homologues. IL-I ~ plasmid injection also induced humoral 
and cellular immunity molecules in Japanese flounder kidney cells6 The specific 
modulation of humoral and cellular immunity is the main basis for the prolonged 
immunity in DNA and adjuvant immunizations.16 The up-regulation of both humoral and 
cellular immunity molecules in response to cytokine plasmid injection suggests that 
microarrays can be used as a reliable tool to develop effective vaccines. 
A number of functionally unknown genes were also up-regulated, especially at I 
and 3 days after the injection of plasmid-encoded chemokines. The observed up-
regulation of such genes during the early stages of post-plasmid injection suggests that 
they are involved in non-specific immunity in fish or that they trigger the expression of 
specific cellular and humoral responses. A potential area of research is to characterize 
some of the up-regulated unknown genes. This would identifY novel immune-related 
genes. 
The results of this study clearly document the role of fish cytokines as genetic 
adjuvants and still further studies are needed especially in the quantification of dosage 
and duration of immunity to develop effective vaccines using these cytokine genes. 
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Chapter 4 
Cloning, characterization and expression analysis 
of interferon-induced protien-lO (IP-IO) in 
Japanese flounder (Paralichthys olivaceus) 
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4.1. ABSTRACT 
Interferon-inducible protein (IP-IO) was identified for the first time in fish from 
Japanese flounder. The gene was obtained from brain cells stimulated with poly I:C. The 
cDNA consists of 677 bp with a 27 bp 5' UTR, a 336 open reading frame encoding a III 
amino acid peptide and a 3 14 bp 3' UTR. The gene has four cysteine residues, which are 
conserved, with first two cysteines separated with histidine. Homology and Phylogenetic 
analysis revealed that the gene was found to be closer to human IP-IO. Identities were 
significantly low to the SCYBA gene cloned from zebrafish , eventhough it shared the 
same cluster. The gene was transcribed from an early time point by stimulation with LPS 
and poly I:C. 
Keywords: fisbj cytokinesj innate immunityj inflammationj mitogensj RT -PCR 
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4.2. INTRODUCTION 
Chemokines are a super family of small related protein molecules that are 
secreted by a variety of cells and their ability to recruit a wide range of immune cells to 
the sites of infection and disease. These molecules act as chemo-attractants causing an 
influx of neutrophils, monocytes, T-cells and basophils in humans. Chemokines are 
classified into four groups: CXC(a ), CC(~), C(y) and CX3C(/i) based on the arrangement 
of first two cystein residues within the protein I In CXC chemokines the two N-terminal 
cysteines are separated by one intervening aminoacid. 
Chemokines in teleosts have been broadly investigated during the past few years. 
Most fish chemokines have been described from molecular cloning of their cDNAs and 
from deducing their aminoacid sequences. Interferon-inducible protein- I 0 (IP-IO) is 
member of a CXC chemokine super family of proinflammatory cytokines having 
chemotactic, mitogenic and immuno-modulatory activitiesZ. It was induced by lFN-y and 
LPS 3. IP-IO is constitutively expressed in lymphoid organs4 IP- IO is also expressed in 
many inflammatory diseasess. 
In the present study, we describe the isolation, characterization and expression 
analysis of a cDNA transcript encoding lP-1 0 for the first time in teleosts. 
4.3. MATERIALS AND METHODS 
4.3.1. Construction of eDNA library 
Total RNA was isolated from Japanese flounder brain cells stimulated with poly 
IC at I hr and 3 hr. The mRNA was purified using a quick prep micro mRNA kit 
(Amersham Biosciences, U.S.A) following the manufacturer's instructions. cDNA 
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synthesis was performed uSing a SMART cONA library construction kit (BD 
Biosciences, U.S.A), in a pTriplEx2 cloning vector (BD Biosciences, U.S.A) following 
the manufacturer' s instructions. 
4.3.2. Cloning of [polO 
A partial cDNA clone of !P-I 0 obtained from the brain cDNA library, was used 
as a DNA probe to screen a full length cDNA of IP-l O. The hybridization was conducted 
as previously reported 6. The plasmid DNA was extracted by alkaline lysis method7• The 
cDNA clones nucleotide sequences are determined on an automated DNA sequencer 
LC4200 (Li-cor, U.S.A). The nucleotide and deduced amino acid sequences were 
analyzed by using GENETYX windows version 8.0 (SOC software Development, Japan). 
Each obtained cDNA sequence was compared with sequences deposited in 
DDBJIEMBUGenBank using the BLASTX and BLASTP programs [National Center for 
Biotechnology Information (NCB!), available at http://www.ncbi.nlm.nih.govIBLAST1. 
The signal !P program was used to predict the cleavage site between the signal peptide 
and mature !P-IO (available at http://www.cbs.dtu.dklservices/signaIPD8. 
4.3.3. Alignment analysis and Phylogenetic tree construction 
The amino acid and nucleotide sequences of IP-l 0 genes were retrieved from 
NCBI databases. Multiple alignments of IP-I 0 genes were carried out using clustal X 
program 9. A phylogenetic tree of IP-l 0 genes based on amino acids was constructed with 
the neighbor-joining method using the PHYL!P program. The values supporting each 
node are derived from 100 resamplings. 
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4.3.4.IP-IO gene expression in flounder tissues 
Total RNA was extracted from healthy Japanese flounder brain, eye, gill, head 
kidney, heart, intestine, liver, muscle, ovary, PBLs, skin, spleen, stomach and post kidney 
using Trizol Reagent (Invitrogen, USA). The first strand cDNA was synthesized using 
first strand cDNA synthesis kit with AMV reverse transcriptase following the 
manufacturer's instructions (Life Sciences, USA). One microliter of reverse-transcribed 
reaction from each tissue was used as a template for PCR amplification. The primers used 
in this experiment were listed in Table.1. A ~-actin primer set 10 was used as a positive 
control. The PCR reaction was conducted with an initial denaturation step at 9S °c for 2 
min, followed by 30 cycles of 9S °c for 30 s, SS °c for 30 s, and 72 °c for I min. The 
reacted products were electrophoresed on a 2% agarose gel containing ethidium bromide 
(100 ng/ml). 
4.3.5. IP-IO gene expression in vitro 
Head kidney cells of Japanese flounder were stimulated by treatment with Con A 
(O.OS IJg), PMA (0.1 lJg/ml), LPS (O.S mg/ml) and poly [:C (S.O IJg) at I, 3 and 6 hr 
intervals. 
Table I RT-PCR primers for IP-IO expression anlysis 
Clone Accession no. Gene Primer (-
BI20 AU090737 ~-actin (sense) S'-TGA TGAAGCCCAGAGCAAGA-3' 2: 
~-actin ( antisense~ S'-CTCCATGTCATCCCAGTTGG-3' 
IP-IO Not submitted !P-IO (sense) S'-CGAAGATGAAGCTGCAG-3' 
[P-IO (antisense~ S'-ATAGCGA TTCAGAAGTCCGG-3' 
Total RNA was extracted by Trizol Reagent (Invitrogen, USA) following manufacturer's 
instructions. The first strand cDNA was synthesized using first strand cDNA synthesis kit 
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with AMV reverse transcriptase following the manufacturer's instructions (Life Sciences, 
USA). One microliter of reverse-transcribed reaction from each sample was used as a 
template for PCR amplification. The primers used in this experiment were listed in 
Table.!. A ~-actin primer setlO was used as a positive control. The PCR reaction was 
conducted with an initial denaturation step at 95°C for 2 min, followed by 30 cycles of 
95 °c for 30 s, 55°C for 30 s, and 72 °c for I min. The reacted products were 
electrophoresed on a 2% agarose gel containing ethidium bromide (100 nglml). 
4.4. RESULTS AND DISCUSSION 
Chemokines are key components in the process of leukocyte recruitment 10 
inflammatory sites. The interaction of various chemokines with their receptors on 
leukocytes allows activation of chemotaxis of neutrophils, eosinophils, lymphocytes, 
monocytes necessary for migration to the sites of evolving inflammation. We have 
identified interferon inducible protein-IO (IP-IO) for the first time in teleosts from 
Japanese flounder brain cDNA library stimulated with Poly I:C. The identification and 
cloning of Japanese flounder CXC chemokine was based on the EST analysis. Poly I:C is 
known to trigger a wide range of cellular responses, including the production of cytokines 
and chemokines. The Japanese flounder cDNA consists of 677 bp with a 27 bp 5' UTR, a 
336 open reading frame encoding a III amino acid peptide and a 314 bp 3' UTR (Fig. I). 
The 3' UTR contains a single typical polyadenylation signal (AA T AAA) and three 
instability motifs (ATITA) responsible for rapid degradation ofmRNA (Fig. I), as is the 
case with other inflammatory molecules II . The presence of consensus sequence in other 
CXC chemokines in fishes 12. The predicted cleavage site of the signal sequence to 
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Fig.l 
1 CCACGCGTCCGCAAAGCCTCCGCGAAGATGATGAAGCTGCAGAAACCACTGCTCCTCCTG 60 
M M K L Q K P L L L L 
~ 
61 GCTGCTCTGACGCTCTGCTGCTGCATCGACACTCTGCACGCCTTTCGTCAGCGGGGGTGT 120 
A A L T L C C C lOT L H A F R Q R G C 
121 CACTGCATCCGGACGACTCCCGATAAAGTCCCCGTTAGGTTCATCAAGAAACTTGAGGTG 180 
H C I R T T P 0 K V P V R F I K K LEV 
181 ATCCCTATTTCGGGACAATGTCGCCGGACTGAGATCATCATCACGAAGAGAAACGGCTAC 240 
I PIS G Q C R R TEl I I T K R N G Y 
241 AAACTCTGTGTGGCTCCAGAAGAGAAGTGGATCAAGGACCTGCTCGGATATCTGCAGAGT 300 
K L C V APE E K W I K 0 L L G Y L Q 5 
301 GAAAATGAGACGACTGACAAAACCAGCATTTCAACCACCCATTCTCCCGCCCCGGACTTC 360 
ENE T T 0 K T 5 1ST T H 5 PAP 0 F 
361 TGAATCGCTATATTTATCATCACACCCCCAATTTACTTACAAGCTGTGAATTAGATGTAG 420 
• 
421 GACAGTTGA TTT A TGGTTCAACCTTT AACACCAGTCTTCTGCCACTGA TTGGTGTTTCTT 480 
481 CCCTTTGGATTTTATATTATTAAACTTTGTTCACTGAGCAAGTGAGAAACTTTATCTCAC 540 
541 TGCAGTTTCACATATTCTTCTCTGAAACTGTTCAAATGTGTCAGCGTTGACATTTTGTCA 600 
601 TCAGGAAATGTAATTTGAAGCA •••• ACTGATTCTTTTAATAAAAATCTGATGTTTTAAA 660 
661 AAAAAAAAAAAAAAA 677 
I. Complete full length Japanese flounder IP-IO cDNA sequence. Start and stop 
codon, RNA instability motifs (ATITA)in the 3' untranslated region are indicated 
in bold letters. The vertical arrow indicates the signal peptide cleavage site. The 
polyadenylation signal (AA T AAA) is underlined. Stop codon is also given 
asterisk mark. 
the mature protein is between phenyl alanine and Arginine. The mature peptide has four 
cysteine residues, which are conserved, with first two cysteines separated with histidine 
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(Fig.2). Japanese flounder IP-I 0 has all the four cysteines and in conserved positions as 
found in mammalian IP-lOs. It is interesting to note that histidine separates the first two 
cysteines forming the CXC motif. 
Interestingly, the ELR (Glutamate-leucine-arginine) motif, which is associated 
with specificity to neutrophil between the N-terminus and the first cysteine is absent in 
IP-IO (Fig.2). Japanese flounder IP-IO is longer than the human IP-IO. The amino acid 
sequence of Japanese flounder draws highest identity (Fig. 2) to mouse IP-IO (47.3%) 
followed by human (44.1%), Macaque (42.S), sheep IP-IO (41.6%) and goat IP-IO 
(40.5%) when mature protein was compared (Table 2). A molecular Phylogenetic tree 
was constructed to further analyze the evolutionary relationship with known IP-IO 
chemokines. The phylogenetic analysis revealed that Japanese flounder JP-IO is closely 
related with zebrafish SCYBA, and human, macaque, sheep and goat IP-IOs (Fig. 3). In 
unison to the percentage identity, the Japanese flounder IP-IO occupied a different clad in 
relation to the zebrafish SCYBA and was closely related to human IP-IO. According to 
Najakshin et a!. (1999) 13 early divergence of CXC type chemokine lead to three basic 
types: SDF, IL-S and 1-T AC. The CXC chemokines so far isolated in fish are homologues 
of human IL-S like chemokines 14. Japanese flounder IP-IO is also of IL-S type. Japanese 
flounder IP-IO shows higher homology to mouse and human IP-I O. IL-2 and interferons 




Jflounder l:MMKLQKPLLLLAALTLCCCIDTLHAFRQRG~H~IRTTPDKVPVRFIKKLEVIPISG~RR 60 
ZfishSCYBA l :-----MNRcSTAALFLLvIAv~SLNTEAYKCRCTR-KGPKIRYIDVQKLEIKPKHPYCQE 54 
Sheep l:-MNKSGFLIFCLILLTLS--QGIPLSRNTRCTCIEISNGSVNPRSLEKLELIPASQSCPR 57 
Goat l:-MNTSGFLIFCLILLTLS--QGIPLSRNTRCTCIEISNGSVNPRSLEKLELIPASQSCPR 57 
Human l : -MNQTAILICCLIFLTLSGIQGVPLSRTVRCTCISISNQPVNPRSLEKLEIIPASQFCPR 59 
Rat l:-MNPSAAVVLCLVLLSLSGTQGIPLARTVRCTCIDFHEQPLRPRAIGKLEIIPASLSCPH 59 
CottonRat l :-MNPSAVLVFCLILLSLSGTQGIPHSRTVRCFCNKTEDRLLRPRALEKLEIIPASLSCPR 59 
Mouse l : -MNPSAAVIFCLILLGLSGTQGIPLARTVRCNCI HIDDGPVRMRAIGKLEIIPASLSCPR 59 
Hamster l :-MNASAILLFCLILLSLSGTQGIPLSRTVRCSCIKIDDRPVKPRALGKLEIIPASQSCPR 59 
Macaque l:-MNQTAILICCLVFLTLSGIQGIPLSRTVRCTCISISNQPVNPRSLEKLEIIPPSQFCPH 59 
• .. * .. . . • . . . I> • • 
.. 
Jflounder 61:TEIIIT-----KRNGYKLCVAPEEKWIKDLLGYLQSENETTDKTSISTTHSPAPDF 111 
ZfishSCYBA 55:KMIFVTMENVSRFKGQEYCLHPRLQSTRNLVKWFKIWKDKHRTFEA---------- 100 
Sheep 58 :VEIIATM----KRNGEKRCLNPESKTIKNLLKAINKQRTKRSPRTQKEA------- 102 
Goat 58:VEIIATM----KRNGEKRCLNPESKTIKNLLKAINKQRTKRSPRTRKEA- ------ 102 
Human 60:VEIIATM----KKKGEKRCLNPESKAIKNLLKAVSKEMSKRSP------------- 98 
Rat 60 :VEIIATM----KKNNEKRCLNPESEAIKSLLKAVSQRRSKRAP------------- 98 
CottonRat 60 :MEIIATM----KKTEKKRCLNPESAAIKNLLKEISRKNV----- - - ---------- 94 
Mouse 60 :VEIIATM----KKNDEQRCLNPESKTIKNLMKAFSQKRSKRAP------------- 98 
Hamster 60:VEIIVTM----KKTEEKRCLNPESEAIKSLLKAVSQRRSKRAS------------- 98 
Macaque 60 :VEIIATM----KKKGEKRCLNPESKAIKNLLKAVSEKKSKRPP------------- 98 
• • •• • .. .. . . ...... ... . .. .. .. . 
Fig. 2 Alignment of the predicted Japanese flounder IP-I 0 translation with other known 
IP-lOs. Identical (*) and similar (.) residues identified by CLUST AL are indicated. 
Triangles indicate the CXC motif. 
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Table 2 Amino acid percentage homology of Japanese flounder IP-l 0 with other known 
IP-IO genes 










the interferon and lL-2 genes may be present in fish but not yet cloned in fish. lP- \0 and 
Mig have selectivity to T -cells that have been stimulated by lL-2 and interferon. This 
results in the recruitment of activated/effector T cells thereby, initiating the effector T cell 
immunity IS. Furthermore, chemokines are known to exert their biological activities 
through G-protein coupled receptors of the target cells. In mammals, receptors of CXC 
and CC have been identified. The lP-1 0 has specificity to CXCR3, which is expressed on 
activated T cells and is important in selective recruitment of T cells during inflammation 
16. However functional studies have to be carried out to know the receptor specificity of 
Japanese flounder lP-1 0 and its role during inflammation. 
A survey of IP-I 0 transcript expression in normal tissues was undertaken. lP- \0 
was detected in ovary, kidney, spleen, eye, skin and gill of healthy Japanese flounder. 
The IP-l 0 expression was not seen in the brain or heart (Fig. 4). These results confirming 
observations that constitutive expression of IP-I 0 in normal tissue is generally quite low 
\07 
Fig. 3 
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,.-_____________ C.no nll . , 
.---_ JU. un • • , 
'-__ llll~'Cl"" 
.----.. ,
Fig. 3 Phylogenetic tree showing the relationship between the full-length Japanese 
flounder IP-lO amino acid sequence with other representative iP-lO sequences in 
different vertebrate groups. The tree was constructed by the ' neighbour-joining' method 
using the CLUST AL and PHYLIP packages. 
17. After poly i:C and LPS induction of kidney cells the iP-lO expression was transcribed 
at an higher level (Fig. 5). The poly i:C and LPS challenge at various time intervals 
indicated that the IP-l 0 is induced at an early time point and the message is strong in the 
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early period of induction. Although the physiological role of lP-IO remains to be 
determined, it probably participates in inflammatory processes. Furthermore, !P-IO has 
been shown to be a chemoattractant for monocytes and acti vated T cells 18. The 
chemokines demonstrate protracted expression kinetics. The expression of the gene may 
reflect the importance in acute and chronic stresses in fish. At tissue level , the expression 




2 3 4 5 6 7 8 9 10 11 12 13 14 
•• •• 4IIIIIIII'.. ... • • • 
• ~ •• { J ( J .. _ J I.._.J ., l) '-~) (_ 1 t.. ) ( ) <. } 
I Brain, 2 Eye, 1 Gill . 4 Head kidney, S Heart. 6 Intestine, 7 Liver, 8 Muscle, 9 Ovary, 10 PBLs, 11 Skin, 12 Spleen, 
13 Stomach., 14 Post kIdney 
Fig. 4 Transcripts of !P-I 0 from different organs of Japanese flounder 
Fig. 5 
Control CODA PMA LPS Poly I:C 
HOlIn: 1 3 6 I 3 6 1 3 6 3 6 1 3 6 
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Fig. 5 Expression analysis of head kidney cells stimulated with ConA, PMA, LPS and 
poly I:C. 
We have cloned cDNA of [P-IO in teleosts for the first time. The cDNA and 
expression data will provide a solid basis for conducting further functional studies of this 
gene. 
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Cytokines are low molecular weight soluble proteins secreted by the cells of the 
innate and adaptive immunity that mediate many of the functions of these cells. They are 
often pleotropic and redundant. In the present study we investigated the adjuvant effects 
of IL-I~ , IL-S homologue of CXC chemokine and JFCC I which is a homologue of MIP-
10 using VHSV as a model system. We also enumerated the transcriptional profiles of 
Japanese flounder kidney cells induced by IL-I~, IL-S and JFCC I to know how these 
genes influence the fish immune system as a whole. 
In this study, IL-I~, IL-S and JFCC I full-length gene sequences were cloned in 
DNA vaccine expression vector driven by CMV promoter. In vitro transcription and 
translation was done to know whether the nucleotide sequences were translated into 
protein or not. Later the plasmids were extracted in a large scale and purified by ethidium 
bromide-cesium chloride ultra centrifugation. The adjuvants were injected into Japanese 
flounder fish along \vith VHS g vaccine. The fish were challenged \'lith I X I OJ TCIOso by 
intra/peritoneal injection. The RPS and cumulative mortalities were recorded. In the 
second part of study, IL-I~, IL-S, JFCC I and empty vector expression plasmids were 
injected into Japanese flounder fish and the kidney tissue was extracted at I day, 3 day 
and 7 day post-intra/muscular injection. Total RNA was extracted and was converted into 
cDNA. The cDNA was labeled \'lith Cy3 and Cy5 fluorescent substances. The labeled 
sample was hybridized with cDNA microarray chip. After washing the microarray slide 
was scanned with Genepix 4000b scanner. The results were analyzed by using computer. 
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In Chapter 2 we described cloning, characterization and expression of lL-I p and 
transcriptional profiling of Japanese flounder kidney cells induced by lL-I p. IL-I P cDNA 
found to consist of 1329 bp, encoded 247 amino acid residues. The expression of IL-IP 
was induced by treatment with ConAlPMA and LPS. The copy number of JL-I P mRNA 
was increased 30 fold after stimulation with ConAlPMA. Of 871 cDNA on a microarray, 
10.7% of the genes were up-regulated or down-regulated by IL-IP at 1, 3 and 7 days post 
injection. The induced gene expression was highest on I day followed by 3 day and 7 
day. Seven percent of known and 3.7% of unknown genes of the 871 tested genes were 
differentially expressed. Cytokine genes such as tumor necrosis factor, G-CSF and 
chemokine receptor A were induced in response to IL-I p. Cell surface antigens such as Ig 
M, MHC class I and CD20 receptor were up-regulated. Signal transduction genes such as 
Toll-like receptor I and SH3P2 were also up-regulated. The glucocorticoid receptor and 
cAMP early repressor were down regulated in our microarray analysis. 
In chapter 3 we described adjuvant effects of IL-I p, IL-8 and lFCC I against 
VHSV and also the analysis of the immune response of IL-8 and JFCC I genes using 
cDNA microarrays. The adjuvants used in this study were able to provide protection 
against VHS virus and this lasted until 21 days after challenge. The adjuvants vaccine 
had high protective efficiency, giving relative percentage survival values of at least 70%. 
The defense mechanisms activated by two of the cytokines (lL-8, JFCC I) were further 
elucidated by microarray analysis. IL-8 up-regulated genes such as IL-8, CC chemokine 
receptor A, lysozyme, Ig M and p2-microglobulin. 
In chapter 4 we described cloning, characterization and expression analysis of 
interferon-inducible gene-I O. JP-IO is also a chemokine which can be used as adjuvant in 
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vaccine studies. In our phylogenetic analysis we found that it is closely related to human 
IP-IO. 
In conclusion, IL-l~, IL-8 and JFCCI showed adjuvant effects in DNA vaccine 
against VHSV in our study. All these three genes are strong mediators of innate 
immunity, humoral immunity and cellular immunity mechanisms. All three genes 
induced inflammatory related genes. IL-l ~ alone exhibited the signal transduction 
inducer property. Still further studies are needed especially in the quantification of 
dosage and duration of immunity to assess long lasting adjuvant properties of these 
cytokine genes. 
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